- approval_date: 2020-04-27
  device: U-TOP COVID-19 Detection Kit
  entity: SEASUN BIOMATERIALS
  last_update: 2020-09-01
  links:
  - href: https://www.fda.gov/media/137420/download
    title: U-TOP COVID-19 Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137422/download
    title: U-TOP COVID-19 Detection Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137421/download
    title: U-TOP COVID-19 Detection Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137425/download
    title: U-TOP COVID-19 Detection Kit - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/141799/download
    title: U-TOP COVID-19 Detection Kit - Letter Granting EUA Revision(s) (September
      1, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-23
  device: STANDARD M nCoV Real-Time Detection Kit
  entity: SD Biosensor, Inc.
  last_update: 2020-04-23
  links:
  - href: https://www.fda.gov/media/137303/download
    title: 'SD Biosensor EUA Letter of Authorization '
    type: letter of authorization
  - href: https://www.fda.gov/media/137301/download
    title: SD Biosensor Fact Sheet for HCP
  - href: https://www.fda.gov/media/137304/download
    title: SD Biosensor Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137302/download
    title: SD Biosensor Information for Use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-22
  device: RealStar SARS-CoV02 RT-PCR Kits U.S.
  entity: altona Diagnostics GmbH
  last_update: 2020-04-22
  links:
  - href: https://www.fda.gov/media/137257/download
    title: 'altona Diagnostics GmbH Letter of Authorization '
    type: letter of authorization
  - href: https://www.fda.gov/media/137251/download
    title: altona Diagnostics GmbH Fact Sheet HCP
  - href: https://www.fda.gov/media/137254/download
    title: altona Diagnostics GmbH Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137252/download
    title: altona Diagnostics GmbH Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-02-04
  device: CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC)
  entity: Centers for Disease Control and Prevention's (CDC)
  last_update: 2020-07-13
  links:
  - href: https://www.fda.gov/media/134919/download
    title: CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/134920/download
    title: CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC) - Fact Sheet for
      Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/134921/download
    title: CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC) - Fact Sheet for
      Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/134922/download
    title: CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC) - Manufacturer Instructions/Package
      Insert
    type: instructions for use
  - href: https://www.fda.gov/media/136572/download
    title: CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC) - Letter Granting
      EUA Amendments
    type: letter of authorization
  - href: https://www.fda.gov/media/138931/download
    title: CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC) - Letter Granting
      EUA Amendment(s) (June 12, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/140088/download
    title: CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC) - Letter Granting
      EUA Amendment(s) (July 13, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-02-29
  device: New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic
    Panel
  entity: Wadsworth Center, New York State Department of Public Health's (CDC)
  last_update: 2020-03-15
  links:
  - href: https://www.fda.gov/media/135661/download
    title: New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic
      Panel - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/135662/download
    title: New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic
      Panel - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/135663/download
    title: New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic
      Panel - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/135847/download
    title: New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic
      Panel - Manufacturer Instructions/Package
    type: instructions for use
  - href: https://www.fda.gov/media/136122/download
    title: New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic
      Panel (Wadsworth Center, NYSDOH) - Letter Granting EUA Amendment(s) (March 15,
      2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-04-24
  approval_date: 2020-03-26
  device: Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2
  entity: BGI Genomics Co. Ltd
  last_update: 2020-04-24
  links:
  - href: https://www.fda.gov/media/136473/download
    title: Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV (BGI Genomics
      Co. Ltd) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136471/download
    title: Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV (BGI Genomics
      Co. Ltd) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136474/download
    title: Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV (BGI Genomics
      Co. Ltd) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136472/download
    title: Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV (BGI Genomics
      Co. Ltd) - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/137354/download
    title: Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 - Amendments
      - April 24, 2020
    type: amendment
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-03-20
  device: Xpert Xpress SARS-CoV-2 test
  entity: Cepheid
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/136316/download
    title: Cepheid Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136313/download
    title: Cepheid Factsheet for Health Care Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136312/download
    title: Cepheid Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136314/download
    title: Cepheid Instructions Package Insert Labs
    type: instructions for use
  - href: https://www.fda.gov/media/136315/download
    title: Cepheid Instructions Package Insert Point of Care
    type: instructions for use
  - href: https://www.fda.gov/media/136856/download
    title: Xpert Xpress SARS-CoV-2 test - Letter Granting EUA Amendment(s) (April
      8, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/140985/download
    title: Cepheid Xpert Xpress SARS-CoV-2 test - Letter Granting EUA Amendment(s)
      (August 8, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  - W
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-03-20
  device: Primerdesign Ltd COVID-19 genesig Real-Time PCR assay
  entity: Primerdesign Ltd.
  last_update: 2020-04-08
  links:
  - href: https://www.fda.gov/media/136306/download
    title: Primerdesign Ltd COVID-19 genesig Real-Time PCR assay (Primerdesign Ltd)
      - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136822/download
    title: 'Primerdesign Ltd COVID-19 genesig Real-Time PCR assay (Primerdesign Ltd)
      - Fact Sheet for Health Care Providers '
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136307/download
    title: Primerdesign Ltd COVID-19 genesig Real-Time PCR assay (Primerdesign Ltd)
      - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136823/download
    title: 'Primerdesign Ltd COVID-19 genesig Real-Time PCR assay (Primerdesign Ltd)
      - Instructions for Use '
    type: instructions for use
  - href: https://www.fda.gov/media/136824/download
    title: Primerdesign SARS-CoV-2 Assay - Letter Granting EUA Amendment(s) (April
      8, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-03-19
  device: ePlex SARS-CoV-2 Test
  entity: GenMark Diagnostics, Inc.
  last_update: 2020-08-18
  links:
  - href: https://www.fda.gov/media/136283/download
    title: ePlex SARS-CoV-2 Test (GenMark Diagnostics) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136281/download
    title: ePlex SARS-CoV-2 Test (GenMark Diagnostics) - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136284/download
    title: ePlex SARS-CoV-2 Test (GenMark Diagnostics) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136282/download
    title: ePlex SARS-CoV-2 Test (GenMark Diagnostics) - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/141300/download
    title: ePlex SARS-CoV-2 Test - Letter Granting EUA Revision(s) (August 18, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  technology: RT-PCR and electrochemical detection
  type: diagnostic
- approval_date: 2020-03-19
  device: Simplexa COVID-19 Direct assay
  entity: DiaSorin Molecular LLC
  last_update: 2020-06-04
  links:
  - href: https://www.fda.gov/media/136288/download
    title: Simplexa COVID-19 Direct assay (DiaSorin Molecular) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136285/download
    title: Simplexa COVID-19 Direct assay (DiaSorin Molecular) - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136287/download
    title: Simplexa COVID-19 Direct assay (DiaSorin Molecular) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136286/download
    title: Simplexa COVID-19 Direct assay (DiaSorin Molecular) - Instructions for
      Use
    type: instructions for use
  - href: https://www.fda.gov/media/136488/download
    title: Simplexa COVID-19 Direct assay - Letter Granting EUA Amendment(s) (March
      26, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/136940/download
    title: Simplexa COVID-19 Direct assay - Letter Granting EUA Amendment(s) (April
      13, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/138665/download
    title: DiaSorin Molecular LLC Simplexa COVID-19 Direct assay - Letter Granting
      EUA Amendment(s) (June 4, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-07-30
  approval_date: 2020-03-18
  device: Abbott RealTime SARS-CoV-2 assay
  entity: Abbott Molecular
  last_update: 2020-07-30
  links:
  - href: https://www.fda.gov/media/136255/download
    title: Abbott RealTime SARS-CoV-2 assay (Abbott Molecular) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136256/download
    title: Abbott RealTime SARS-CoV-2 assay (Abbott Molecular) - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136257/download
    title: Abbott RealTime SARS-CoV-2 assay (Abbott Molecular) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136258/download
    title: Abbott RealTime SARS-CoV-2 assay (Abbott Molecular) - Manufacturer Instructions/Package
      Insert
    type: instructions for use
  - href: https://www.fda.gov/media/136617/download
    title: Abbott RealTime SARS-CoV-2 assay - Letter Granting EUA Amendment(s) (April
      1, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/140667/download
    title: Abbott RealTime SARS-CoV-2 assay - Amendment July 30, 2020
    type: amendment
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-03-17
  device: Quest SARS-CoV-2 rRT-PCR
  entity: Quest Diagnostics Infectious Disease, Inc.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/136228/download
    title: Quest SARS-CoV-2 rRT-PCR (Quest Diagnostics Infectious Disease, Inc.) -
      Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136229/download
    title: Quest SARS-CoV-2 rRT-PCR (Quest Diagnostics Infectious Disease, Inc.) -
      Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136230/download
    title: Quest SARS-CoV-2 rRT-PCR (Quest Diagnostics Infectious Disease, Inc.) -
      Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136231/download
    title: Quest SARS-CoV-2 rRT-PCR (Quest Diagnostics Infectious Disease, Inc.) -
      Manufacturer Instructions/Package Insert
    type: instructions for use
  - href: https://www.fda.gov/media/138402/download
    title: Quest Diagnostics Infectious Disease, Inc. Quest SARS-CoV-2 rRT-PCR - IFU
      (Home Collect)
  - href: https://www.fda.gov/media/136487/download
    title: Quest SARS-CoV-2 rRT-PCR - Letter Granting EUA Amendment(s) (March 26,
      2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/140607/download
    title: Quest SARS-CoV-2 rRT-PCR - Letter Granting EUA Amendment(s) (July 28, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection, Pooling
  type: diagnostic
- approval_date: 2020-03-17
  device: Lyra SARS-CoV-2 Assay
  entity: Quidel Corporation
  last_update: 2020-04-08
  links:
  - href: https://www.fda.gov/media/136224/download
    title: Lyra SARS-CoV-2 Assay (Quidel Corp.) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136821/download
    title: Lyra SARS-CoV-2 Assay (Quidel Corp.) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136225/download
    title: Lyra SARS-CoV-2 Assay (Quidel Corp.) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136820/download
    title: 'Lyra SARS-CoV-2 Assay (Quidel Corp.) - Manufacturer Instructions/Package
      Insert '
    type: instructions for use
  - href: https://www.fda.gov/media/136819/download
    title: Lyra SARS-CoV-2 Assay (Quidel Corp.) - Letter Granting EUA Amendment(s)
      (April 8, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-10-19
  approval_date: 2020-03-16
  device: COVID-19 RT-PCR Test
  entity: Laboratory Corporation of America (LabCorp)
  last_update: 2020-09-18
  links:
  - href: https://www.fda.gov/media/136148/download
    title: COVID-19 RT-PCR Test (Laboratory Corporation of America) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136149/download
    title: COVID-19 RT-PCR Test (Laboratory Corporation of America) - Fact Sheet for
      Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136150/download
    title: COVID-19 RT-PCR Test (Laboratory Corporation of America) - Fact Sheet for
      Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136151/download
    title: COVID-19 RT-PCR Test (Laboratory Corporation of America) - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/137154/download
    title: LabCorp COVID-19 RT-PCR Information for Use - Home Collection
  - href: https://www.fda.gov/media/139732/download
    title: LabCorp Home Collect - Information for Use
  - href: https://www.fda.gov/media/136973/download
    title: LabCorp Covid-19 Amendments
    type: amendment
  - href: https://www.fda.gov/media/139733/download
    title: EUA-LabCorp-Amendment-Letter07022020
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection, Pooling, Screening
  type: diagnostic
- approval_date: 2020-03-16
  device: Panther Fusion SARS-CoV-2 Assay
  entity: Hologic, Inc.
  last_update: 2020-09-23
  links:
  - href: https://www.fda.gov/media/136153/download
    title: Panther Fusion SARS-CoV-2 (Hologic, Inc.) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136154/download
    title: Panther Fusion SARS-CoV-2 Assay (Hologic, Inc.) - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136155/download
    title: Panther Fusion SARS-CoV-2 Assay (Hologic, Inc.) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136156/download
    title: Panther Fusion SARS-CoV-2 Assay (Hologic, Inc.) - Manufacturer Instructions/Package
    type: instructions for use
  - href: https://www.fda.gov/media/137368/download
    title: Panther Fusion SARS-CoV-2 Assay - Letter Granting EUA Amendment(s) (April
      24, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Pooling, Screening
  type: diagnostic
- amendments:
  - 2020-10-19
  - 2020-10-19
  approval_date: 2020-03-13
  device: TaqPath COVID-19 Combo Kit
  entity: Thermo Fisher Scientific, Inc.
  last_update: 2020-07-17
  links:
  - href: https://www.fda.gov/media/136113/download
    title: TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, Inc.) - Letter of
      Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136111/download
    title: TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, Inc.) - Fact Sheet
      for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136114/download
    title: TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, Inc.) - Fact Sheet
      for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136112/download
    title: TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, Inc.) - Instructions
      for Use
    type: instructions for use
  - href: https://www.fda.gov/media/136413/download
    title: TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, Inc.) - Letter Granting
      EUA Amendment(s) (March 24, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/137164/download
    title: TaqPath COVID-19 Combo Kit - Amendment - 04-20-2020
    type: amendment
  - href: https://www.fda.gov/media/137922/download
    title: TaqPath COVID-19 Combo Kit - Amendment 05-09-20
    type: amendment
  - href: https://www.fda.gov/media/140298/download
    title: TaqPath COVID-19 Combo Kit - Letter Granting EUA Amendment(s) (July 17,
      2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-03-31
  approval_date: 2020-03-12
  device: cobas SARS-CoV-2
  entity: Roche Molecular Systems, Inc. (RMS)
  last_update: 2020-05-13
  links:
  - href: https://www.fda.gov/media/136046/download
    title: cobas SARS-CoV-2 (Roche Molecular Systems, Inc.) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136047/download
    title: cobas SARS-CoV-2 (Roche Molecular Systems, Inc.) - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136048/download
    title: cobas SARS-CoV-2 (Roche Molecular Systems, Inc.) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136049/download
    title: cobas SARS-CoV-2 (Roche Molecular Systems, Inc.) - Manufacturer Instructions/Package
    type: instructions for use
  - href: https://www.fda.gov/media/136589/download
    title: cobas SARS-CoV-2 - Amendment for March 31, 2020
    type: amendment
  - href: https://www.fda.gov/media/138071/download
    title: RMS Cobas Amenment, May 13, 2020
  method: molecular
  settings:
  - H
  - M
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-03-23
  device: Accula SARS-Cov-2 Test
  entity: Mesa Biotech Inc.
  last_update: 2020-08-24
  links:
  - href: https://www.fda.gov/media/136345/download
    title: Accula SARS-Cov-2 Test (Mesa Biotech Inc.) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136347/download
    title: Accula SARS-Cov-2 Test (Mesa Biotech Inc.) - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136349/download
    title: Accula SARS-Cov-2 Test (Mesa Biotech Inc.) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136355/download
    title: Accula SARS-Cov-2 Test (Mesa Biotech Inc.) - Labeling
  - href: https://www.fda.gov/media/137533/download
    title: MESA ACCULA Letter Granting EUA Amendment
    type: letter of authorization
  - href: https://www.fda.gov/media/141506/download
    title: Accula SARS-Cov-2 Test - Letter Granting EUA Revision(s) (August 24, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  - W
  technology: RT and amplification
  type: diagnostic
- approval_date: 2020-03-23
  device: BioFire COVID-19 Test
  entity: BioFire Defense, LLC
  last_update: 2020-04-30
  links:
  - href: https://www.fda.gov/media/136356/download
    title: BioFire COVID-19 Test (BioFire Defense, LLC) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136357/download
    title: BioFire COVID-19 Test (BioFire Defense, LLC) - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136358/download
    title: BioFire COVID-19 Test (BioFire Defense, LLC) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136353/download
    title: BioFire COVID-19 Test (BioFire Defense, LLC) - Labeling
  - href: https://www.fda.gov/media/137534/download
    title: BIOFIRE Letter Granting EUA Amendment(s)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  technology: RT, Nested multiplex PCR
  type: diagnostic
- approval_date: 2020-03-24
  device: PerkinElmer New Coronavirus Nucleic Acid Detection Kit
  entity: PerkinElmer, Inc.
  last_update: 2020-09-25
  links:
  - href: https://www.fda.gov/media/136407/download
    title: PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136408/download
    title: PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Fact Sheet for
      Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136409/download
    title: PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Fact Sheet for
      Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136410/download
    title: PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Labeling
  - href: https://www.fda.gov/media/136616/download
    title: PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Letter Granting
      EUA Amendment(s) (April 1, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-03-25
  device: AvellinoCoV2 test
  entity: Avellino Lab USA, Inc.
  last_update: 2020-09-25
  links:
  - href: https://www.fda.gov/media/136450/download
    title: AvellinoCoV2 test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136451/download
    title: AvellinoCoV2 test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136452/download
    title: AvellinoCoV2 test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136453/download
    title: AvellinoCoV2 test - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/142444/download
    title: Avellino CoV2 test - Letter Granting EUA Revision(s) (September 24, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-03-27
  device: NxTAG CoV Extended Panel Assay
  entity: Luminex Molecular Diagnostics, Inc.
  last_update: 2020-03-27
  links:
  - href: https://www.fda.gov/media/136497/download
    title: NxTAG CoV Extended Panel Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136498/download
    title: NxTAG CoV Extended Panel Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136499/download
    title: NxTAG CoV Extended Panel Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136500/download
    title: NxTAG CoV Extended Panel Assay - IFU
  method: molecular
  settings:
  - H
  technology: RT-PCR
  type: diagnostic
- amendments:
  - 2020-04-21
  approval_date: 2020-03-27
  device: ID NOW COVID-19
  entity: Abbott Diagnostics Scarborough, Inc.
  last_update: 2020-09-17
  links:
  - href: https://www.fda.gov/media/136522/download
    title: ID NOW COVID-19 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136523/download
    title: ID NOW COVID-19 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136524/download
    title: ID NOW COVID-19 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136525/download
    title: ID NOW COVID-19 - IFU
  - href: https://www.fda.gov/media/137181/download
    title: Abbott Diagnostics Scarborough, Inc. - ID NOW COVID-19 - Amendments 04-21-2020
    type: amendment
  method: molecular
  settings:
  - H
  - M
  - W
  technology: RT, Isothermal amplification
  type: diagnostic
- approval_date: 2020-03-30
  device: QIAstat-Dx Respiratory SARS-CoV-2 Panel
  entity: QIAGEN GmbH
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/136569/download
    title: QIAstat-Dx Respiratory SARS-CoV-2 Panel - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136568/download
    title: QIAstat-Dx Respiratory SARS-CoV-2 Panel - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136570/download
    title: QIAstat-Dx Respiratory SARS-CoV-2 Panel - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136571/download
    title: QIAstat-Dx Respiratory SARS-CoV-2 Panel - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  - M
  technology: Real-time RT-PCR, Multi-analyte
  type: diagnostic
- amendments:
  - 2020-02-01
  approval_date: 2020-03-30
  device: NeuMoDx SARS-CoV-2 Assay
  entity: NeuMoDx Molecular, Inc.
  last_update: 2020-04-23
  links:
  - href: https://www.fda.gov/media/136566/download
    title: NeuMoDx SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136564/download
    title: NeuMoDx SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136567/download
    title: NeuMoDx SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136565/download
    title: NeuMoDx SARS-CoV-2 Assay - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/137355/download
    title: NeuMoDx SARS-CoV-2 Assay - Amendment - 04-23-2020
    type: amendment
  method: molecular
  settings:
  - H
  - M
  technology: RT-PCR
  type: diagnostic
- approval_date: 2020-04-01
  device: COV-19 IDx assay
  entity: Ipsum Diagnostics, LLC
  last_update: 2020-04-01
  links:
  - href: https://www.fda.gov/media/136618/download
    title: COV-19 IDx assay (Ipsum Diagnostics, LLC) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136619/download
    title: COV-19 IDx assay (Ipsum Diagnostics, LLC) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136620/download
    title: COV-19 IDx assay (Ipsum Diagnostics, LLC) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136621/download
    title: COV-19 IDx assay (Ipsum Diagnostics, LLC) - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-02
  device: BioGX SARS-CoV-2 Reagents for BD MAX System
  entity: Becton, Dickinson & Company (BD)
  last_update: 2020-09-22
  links:
  - href: https://www.fda.gov/media/136650/download
    title: BioGX SARS-CoV-2 Reagents for BD MAX System - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136652/download
    title: BioGX SARS-CoV-2 Reagents for BD MAX System - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136651
    title: BioGX SARS-CoV-2 Reagents for BD MAX System - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136653/download
    title: BioGX SARS-CoV-2 Reagents for BD MAX System - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/138478/download
    title: BioGX SARS-CoV-2 Reagents for BD MAX System - Letter Granting EUA Amendment(s)
      (May 29, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2019-10-01
  device: Logix Smart Coronavirus Disease 2019 (COVID-19) Kit
  entity: Co-Diagnostics, Inc.
  last_update: 2020-04-03
  links:
  - href: https://www.fda.gov/media/136684/download
    title: Logix Smart Coronavirus Disease 2019 (COVID-19) Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136685/download
    title: Logix Smart Coronavirus Disease 2019 (COVID-19) Kit - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136686/download
    title: Logix Smart Coronavirus Disease 2019 (COVID-19) Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136687/download
    title: Logix Smart Coronavirus Disease 2019 (COVID-19) Kit - IFU
  method: molecular
  settings:
  - H
  technology: RT-PCR, CoPrimer technology
  type: diagnostic
- approval_date: 2020-04-03
  device: ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit
  entity: ScienCell Research Laboratories
  last_update: 2020-09-22
  links:
  - href: https://www.fda.gov/media/136688/download
    title: ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit
      - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136689/download
    title: ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit
      - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136690/download
    title: ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit
      - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136691/download
    title: ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit
      - IFU
  - href: https://www.fda.gov/media/138666/download
    title: ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit
      - Letter Granting EUA Amendment(s) (June 5, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/142384/download
    title: ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit
      - Letter Granting EUA Revision(s) (September 22, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-03
  device: ARIES SARS-CoV-2 Assay
  entity: Luminex Corporation
  last_update: 2020-05-11
  links:
  - href: https://www.fda.gov/media/136694/download
    title: ARIES SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136692/download
    title: ARIES SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136695/download
    title: ARIES SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136693/download
    title: ARIES SARS-CoV-2 Assay - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/137938/download
    title: EUA Lumi Aries Letter Granting Amendments
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  technology: RT-PCR
  type: diagnostic
- approval_date: 2020-04-06
  device: Gnomegen COVID-19 RT-Digital PCR Detection Kit
  entity: Gnomegen LLC
  last_update: 2020-04-28
  links:
  - href: https://www.fda.gov/media/136735/download
    title: Gnomegen COVID-19 RT-Digital PCR Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136736/download
    title: Gnomegen COVID-19 RT-Digital PCR Detection Kit - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136737/download
    title: Gnomegen COVID-19 RT-Digital PCR Detection Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136738/download
    title: Gnomegen COVID-19 RT-Digital PCR Detection Kit - IFU
  - href: https://www.fda.gov/media/137452/download
    title: Gnomegen Letter Granting EUA Amendment
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-digital PCR
  type: diagnostic
- approval_date: 2020-04-07
  device: Smart Detect SARS-CoV-2 rRT-PCR Kit
  entity: InBios International, Inc
  last_update: 2020-08-24
  links:
  - href: https://www.fda.gov/media/136787/download
    title: Smart Detect SARS-CoV-2 rRT-PCR Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136785/download
    title: Smart Detect SARS-CoV-2 rRT-PCR Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136788/download
    title: Smart Detect SARS-CoV-2 rRT-PCR Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136786/download
    title: Smart Detect SARS-CoV-2 rRT-PCR Kit - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/138598/download
    title: Inbios Smart Letter Granting EUA Amendment
    type: letter of authorization
  - href: https://www.fda.gov/media/141022/download
    title: InBios International, Inc. Smart Detect SARS-CoV-2 rRT-PCR Kit - Letter
      Granting EUA Amendment(s) (August 10, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/141504/download
    title: Smart Detect SARS-CoV-2 rRT-PCR Kit - Letter Granting EUA Revision(s) (August
      24, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-08
  device: QuantiVirus SARS-CoV-2 Test kit
  entity: DiaCarta, Inc
  last_update: 2020-04-08
  links:
  - href: https://www.fda.gov/media/136806/download
    title: QuantiVirus SARS-CoV-2 Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136807/download
    title: QuantiVirus SARS-CoV-2 Test Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136808/download
    title: QuantiVirus SARS-CoV-2 Test Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136809/download
    title: QuantiVirus SARS-CoV-2 Test Kit - IFU
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-08
  device: BD SARS-CoV-2Reagents for BD MAX System
  entity: Becton, Dickinson & Company
  last_update: 2020-09-23
  links:
  - href: https://www.fda.gov/media/136813/download
    title: BD SARS-CoV-2Reagents for BD MAX System - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136815/download
    title: BD SARS-CoV-2Reagents for BD MAX System - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136814/download
    title: BD SARS-CoV-2Reagents for BD MAX System - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136816/download
    title: BD SARS-CoV-2Reagents for BD MAX System - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/138932/download
    title: BD SARS-CoV-2Reagents for BD MAX System - Letter Granting EUA Amendment(s)
      (June 11, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-07-18
  approval_date: 2020-04-10
  device: iAMP COVID-19 Detection Kit
  entity: Atila BioSystems, Inc.
  last_update: 2020-07-18
  links:
  - href: https://www.fda.gov/media/136872/download
    title: iAMP COVID-19 Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136869/download
    title: iAMP COVID-19 Detection Kit - Fact Sheet for Health Care Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136871/download
    title: iAMP COVID-19 Detection Kit - Information for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136870/download
    title: iAMP COVID-19 Detection Kit - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/140334/download
    title: iAMP COVID-19 Detection Kit - Amendment July 18, 2020
    type: amendment
  method: molecular
  settings:
  - H
  technology: RT, Isothermal amplification
  type: diagnostic
- approval_date: 2020-04-15
  device: SARS-CoV-2 Fluorescent PCR Kit
  entity: Maccura Biotechnology (USA) LLC
  last_update: 2020-04-15
  links:
  - href: https://www.fda.gov/media/137023/download
    title: Maccura Biotechnology (USA) LLC SARS-CoV-2 Fluorescent PCR Kit- Letter
      of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137025/download
    title: Maccura Biotechnology (USA) LLC SARS-CoV-2 Fluorescent PCR Kit - Fact Sheet
      for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137024/download
    title: Maccura Biotechnology (USA) LLC SARS-CoV-2 Fluorescent PCR Kit - Fact Sheet
      for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137026/download
    title: Maccura Biotechnology (USA) LLC SARS-CoV-2 Fluorescent PCR Kit - Instructions
      for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-02-01
  approval_date: 2020-04-16
  device: Curative-Korva SARS-Cov-2 Assay
  entity: KorvaLabs Inc.
  last_update: 2020-06-11
  links:
  - href: https://www.fda.gov/media/137088/download
    title: Curative-Korva SARS-Cov-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137087/download
    title: Curative-Korva SARS-Cov-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137086/download
    title: Curative-Korva SARS-Cov-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137089/download
    title: Curative-Korva SARS-Cov-2 Assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/138834/download
    title: Curative-Korva SARS-Cov-2 Assay - Amendment 06-11-2020
    type: amendment
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-16
  device: "GS\"\xA2 COVID-19 RT-PCR KIT"
  entity: GenoSensor, LLC
  last_update: 2020-04-16
  links:
  - href: https://www.fda.gov/media/137090/download
    title: "GS\u2122 COVID-19 RT-PCR KIT - Letter of Authorization"
    type: letter of authorization
  - href: https://www.fda.gov/media/137091/download
    title: "GS\u2122 COVID-19 RT-PCR KIT - Fact Sheet for Healthcare Providers"
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137092/download
    title: "GS\u2122 COVID-19 RT-PCR KIT - Fact Sheet for Patients"
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137093/download
    title: "GS\u2122 COVID-19 RT-PCR KIT - IFU"
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-17
  device: Fosun COVID-19 RT-PCR Detection Kit
  entity: Fosun Pharma USA Inc.
  last_update: 2020-04-17
  links:
  - href: https://www.fda.gov/media/137117/download
    title: Fosun COVID-19 RT-PCR Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137118/download
    title: Fosun COVID-19 RT-PCR Detection Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137119/download
    title: Fosun COVID-19 RT-PCR Detection Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137120/download
    title: Fosun COVID-19 RT-PCR Detection Kit - IFU
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-18
  device: GeneFinder COVID-19 Plus RealAmp Kit
  entity: OSANG Healthcare
  last_update: 2020-04-18
  links:
  - href: https://www.fda.gov/media/137113/download
    title: GeneFinder COVID-19 Plus RealAmp Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137114/download
    title: GeneFinder COVID-19 Plus RealAmp Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137115/download
    title: GeneFinder COVID-19 Plus RealAmp Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137116/download
    title: GeneFinder COVID-19 Plus RealAmp Kit - IFU
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-20
  device: PhoenixDx 2019-CoV
  entity: Trax Management Services Inc.
  last_update: 2020-08-08
  links:
  - href: https://www.fda.gov/media/137150/download
    title: PhoenixDx 2019-CoV - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137152/download
    title: PhoenixDx 2019-CoV - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137151/download
    title: PhoenixDx 2019-CoV - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137153/download
    title: PhoenixDx 2019-CoV - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/137937/download
    title: EUA Trax Phoenix Letter Granting Amendments
    type: letter of authorization
  - href: https://www.fda.gov/media/140984/download
    title: PhoenixDx 2019-CoV - Letter Granting EUA Amendment(s) (August 8, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-21
  device: Allplex 2019-nCoV Assay
  entity: Seegene, Inc.
  last_update: 2020-07-27
  links:
  - href: https://www.fda.gov/media/137179/download
    title: Allplex 2019-nCoV Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137177/download
    title: Allplex 2019-nCoV Assay - Information for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137180/download
    title: Allplex 2019-nCoV Assay - Information for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137178/download
    title: Allplex 2019-nCoV Assay - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/140539/download
    title: Allplex 2019-nCoV Assay - Letter Granting EUA Amendment(s) (July 27, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-29
  device: LabGun COVID-19 RT-PCR Kit
  entity: LabGenomics Co., Ltd.
  last_update: 2020-09-22
  links:
  - href: https://www.fda.gov/media/137484/download
    title: LabGun COVID-19 RT-PCR Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137485/download
    title: LabGun COVID-19 RT-PCR Kit - Information for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137486/download
    title: LabGun COVID-19 RT-PCR Kit - Information for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137483/download
    title: LabGun COVID-19 RT-PCR Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-29
  device: Rheonix COVID-19 MDx Assay
  entity: Rheonix, Inc.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/137490/download
    title: Rheonix COVID-19 MDx Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137488/download
    title: Rheonix COVID-19 MDx Assay - Information for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137491/download
    title: Rheonix COVID-19 MDx Assay - Information for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137489/download
    title: Rheonix COVID-19 MDx Assay - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: RT-PCR
  type: diagnostic
- approval_date: 2020-05-01
  device: Bio-Rad SARS-CoV-2 ddPCR Test
  entity: Bio-Rad Laboratories, Inc
  last_update: 2020-09-18
  links:
  - href: https://www.fda.gov/media/137576/download
    title: Bio-Rad SARS-CoV-2 ddPCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137577/download
    title: Bio-Rad SARS-CoV-2 ddPCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137578/download
    title: Bio-Rad SARS-CoV-2 ddPCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137579/download
    title: Bio-Rad SARS-CoV-2 ddPCR Test - IFU
  method: molecular
  settings:
  - H
  technology: RT-droplet PCR
  type: diagnostic
- approval_date: 2020-05-01
  device: BioFire Respiratory Panel 2.1 (RP2.1)
  entity: BioFire Diagnostics, LLC
  last_update: 2020-05-01
  links:
  - href: https://www.fda.gov/media/137580/download
    title: BioFire Respiratory Panel 2.1 (RP2.1) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137581/download
    title: BioFire Respiratory Panel 2.1 (RP2.1) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137582/download
    title: BioFire Respiratory Panel 2.1 (RP2.1) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137583/download
    title: BioFire Respiratory Panel 2.1 (RP2.1) - IFU
  method: molecular
  settings:
  - H
  - M
  technology: RT, Nested multiplex PCR, Multi-analyte
  type: diagnostic
- approval_date: 2020-05-04
  device: Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence
    Probing)
  entity: Sansure BioTech Inc.
  last_update: 2020-05-04
  links:
  - href: https://www.fda.gov/media/137652/download
    title: EUA Sansure-kit Letter
    type: letter of authorization
  - href: https://www.fda.gov/media/137650/download
    title: EUA Sansure Kit Health Care Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137653/download
    title: EUA Sansure-kit Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137651/download
    title: EUA Sansure-kit IFU
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-05
  device: FTD SARS-CoV-2
  entity: "Fast Track Diagnostics Luxembourg S.\xE1.r.l. (a Siemens Healthineers Company)"
  last_update: 2020-07-09
  links:
  - href: https://www.fda.gov/media/137687/download
    title: Fast Track Diagnostics SARS-CoV-2 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137688/download
    title: Fast Track Diagnostics SARS-CoV-2 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137689/download
    title: Fast Track Diagnostics SARS-CoV-2 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137690/download
    title: Fast Track Diagnostics SARS-CoV-2 - IFU
  - href: https://www.fda.gov/media/139933/download
    title: FTD SARS-CoV-2 - Letter Granting EUA Amendment(s) (July 9, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-06
  device: OPTI SARS-CoV-2 RT PCR Test
  entity: OPTI Medical Systems, Inc.
  last_update: 2020-07-29
  links:
  - href: https://www.fda.gov/media/137737/download
    title: OPTI SARS Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137740/download
    title: OPTI-SARS- Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137738/download
    title: OPTI-SARS Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137739/download
    title: OPTI SARS - Instruction for Use
  - href: https://www.fda.gov/media/138479/download
    title: OPTI SARS-CoV-2 RT PCR Test - Letter Granting EUA Amendment(s) (May 29,
      2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/140637/download
    title: OPTI SARS-CoV-2 RT PCR Test - Letter Granting EUA Amendment(s) (July 29,
      2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-06
  device: Sherlock CRISPR SARS-CoV-2 Kit
  entity: Sherlock BioSciences, Inc.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/137747/download
    title: Sherlock-cris - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137745/download
    title: Sherlock-cris - Letter for Healthcare Providers
    type: letter of authorization
  - href: https://www.fda.gov/media/137748/download
    title: Sherlock-cris - Fact Sheet for Paitents
  - href: https://www.fda.gov/media/137746/download
    title: Sherlock-cris - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: RT-LAMP, CRISPR
  type: diagnostic
- approval_date: 2020-05-06
  device: SARS-COV-2 R-GENE
  entity: "BioM\xE9rieux SA"
  last_update: 2020-05-06
  links:
  - href: https://www.fda.gov/media/137743/download
    title: BioM-Gene - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137741/download
    title: BioM-Gene Fact Sheet for Health Care Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137744/download
    title: BioM-Gene - Factsheet for Patient
  - href: https://www.fda.gov/media/137742/download
    title: BioM - Gene - Instruction for Use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-10
  device: Infinity BiologiX TaqPath SARS-CoV-2 Assay
  entity: Infinity BiologiX LLC
  last_update: 2020-09-18
  links:
  - href: https://www.fda.gov/media/137773/download
    title: Infinity BiologiX TaqPath SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137774/download
    title: Infinity BiologiX TaqPath SARS-CoV-2 Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137771/download
    title: Infinity BiologiX TaqPath SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137782/download
    title: Infinity BiologiX TaqPath SARS-CoV-2 Assay - IFU (Home Collect)
  - href: https://www.fda.gov/media/137772/download
    title: Rutgers SARS Information for Home Collect
  - href: https://www.fda.gov/media/137776/download
    title: Infinity BiologiX TaqPath SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection, Saliva
  type: diagnostic
- amendments:
  - 2020-05-18
  approval_date: 2020-05-07
  device: Quick SARS-CoV-2rRT-PCR Kit
  entity: Zymo Research Corporation
  last_update: 2020-05-28
  links:
  - href: https://www.fda.gov/media/137781/download
    title: Zymo SARS Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137778/download
    title: Zymo SARS Factsheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137779/download
    title: Zymo SARS Factsheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137780/download
    title: Zymo SARS Instruction for Use
  - href: https://www.fda.gov/media/138181/download
    title: Zymo SARS Amendment May 18, 2020
    type: amendment
  - href: https://www.fda.gov/media/138651/download
    title: Zymo Research Corporation Quick SARS-CoV-2rRT-PCR Kit - Letter Granting
      EUA Amendment(s) (May 28, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-08
  device: Gnomegen COVID-19-RT-qPCR Detection Kit
  entity: Gnomegen LLC
  last_update: 2020-05-08
  links:
  - href: https://www.fda.gov/media/137892/download
    title: Gnomegen COVID-19-RT-qPCR Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137893/download
    title: Gnomegen COVID-19-RT-qPCR Detection Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137894/download
    title: Gnomegen COVID-19-RT-qPCR Detection Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137895/download
    title: Gnomegen COVID-19-RT-qPCR Detection Kit - IFU
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-11
  device: 1copy COVID-19 qPCR Multi Kit
  entity: 1drop Inc.
  last_update: 2020-05-11
  links:
  - href: https://www.fda.gov/media/137934/download
    title: EUA 1drop Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137933/download
    title: EUA 1drop Inc. Factsheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137936/download
    title: EUA 1drop Inc - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137935/download
    title: EUA 1drop Inc Instruction for Use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-10-01
  approval_date: 2020-05-11
  device: Alinity m SARS-CoV-2 assay
  entity: Abbott Molecular Inc.
  last_update: 2020-08-24
  links:
  - href: https://www.fda.gov/media/137980/download
    title: EUA Abbott Molecular Inc. Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137978/download
    title: EUA Abbott Molecular Inc. Factsheet for Health Care Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137981/download
    title: EUA Abbott Molecular Inc. Factsheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137979/download
    title: EUA Abbott Molecular Inc. Instruction for Use
  - href: https://www.fda.gov/media/140333/download
    title: Alinity m SARS-CoV-2 assay - Amendment July 20, 2020
    type: amendment
  - href: https://www.fda.gov/media/141505/download
    title: Alinity m SARS-CoV-2 assay - Letter Granting EUA Revision(s) (August 24,
      2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-07-08
  - 2020-07-30
  approval_date: 2020-05-13
  device: Linea COVID-19 Assay Kit
  entity: Applied DNA Sciences, Inc.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/138060/download
    title: DNA Linea - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138058/download
    title: DNA Linea Factsheet - for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138061/download
    title: DNA Linea - Factsheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138059/download
    title: DNA Linea - Instruction for Use
  - href: https://www.fda.gov/media/139870/download
    title: Linea COVID-19 Assay Kit - Amendment July 8, 2020
    type: amendment
  - href: https://www.fda.gov/media/140666/download
    title: Linea COVID-19 Assay Kit - Amendment July 30, 2020
    type: amendment
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-07-24
  approval_date: 2020-05-14
  device: Aptima SARS-CoV-2 assay
  entity: Hologic, Inc.
  last_update: 2020-09-15
  links:
  - href: https://www.fda.gov/media/138097/download
    title: Aptima SARS-CoV-2 assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138095/download
    title: Aptima SARS-CoV-2 assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138098/download
    title: Aptima SARS-CoV-2 assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138096/download
    title: Aptima SARS-CoV-2 assay - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/140430/download
    title: Aptima SARS-CoV-2 assay - Amendment July 24, 2020
    type: amendment
  - href: https://www.fda.gov/media/142194/download
    title: Aptima SARS-CoV-2 assay - Letter Granting EUA Revision(s) (September 15,
      2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: TMA, chemiluminescent
  type: diagnostic
- approval_date: 2020-05-14
  device: NeoPlex COVID-19 Detection Kit
  entity: GeneMatrix, Inc.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/138101/download
    title: NeoPlex COVID-19 Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138099/download
    title: NeoPlex COVID-19 Detection Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138102/download
    title: NeoPlex COVID-19 Detection Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138100/download
    title: NeoPlex COVID-19 Detection Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-06-15
  approval_date: 2020-05-15
  device: Fulgent COVID-19 by RT-PCR Test
  entity: Fulgent Therapeutics, LLC
  last_update: 2020-06-15
  links:
  - href: https://www.fda.gov/media/138147/download
    title: Fulgent COVID-19 by RT-PCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138148/download
    title: Fulgent COVID-19 by RT-PCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138149/download
    title: Fulgent COVID-19 by RT-PCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138150/download
    title: Fulgent COVID-19 by RT-PCR Test - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/139072/download
    title: Fulgent COVID-19 by RT-PCR Test - Instructions for Use (Home Collect)
    type: instructions for use
  - href: https://www.fda.gov/media/139071/download
    title: Fulgent COVID-19 by RT-PCR Test - Amendment June 15, 2020
    type: amendment
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection
  type: diagnostic
- approval_date: 2020-05-15
  device: Everlywell COVID-19 Test Home Collection Kit
  entity: Everlywell, Inc.
  last_update: 2020-09-04
  links:
  - href: https://www.fda.gov/media/138144/download
    title: Everlywell COVID-19 Test Home Collection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138145/download
    title: Everlywell COVID-19 Test Home Collection Kit - IFU
  - href: https://www.fda.gov/media/138146/download
    title: Everlywell COVID-19 Test Home Collection Kit - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/141931/download
    title: Everlywell COVID-19 Test Home Collection Kit - Letter Granting EUA Revision(s)
      (September 4, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - N/A
  technology: Home Collection Kit
  type: diagnostic
- approval_date: 2020-05-15
  device: Assurance SARS-CoV-2 Panel
  entity: Assurance Scientific Laboratories
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/138151/download
    title: Assurance SARS-CoV-2 Panel - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138152/download
    title: Assurance SARS-CoV-2 Panel - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138153/download
    title: Assurance SARS-CoV-2 Panel - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138154/download
    title: Assurance SARS-CoV-2 Panel - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/141342/download
    title: Assurance SARS-CoV-2 Panel - Instructions for Use (Home Collect)
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection
  type: diagnostic
- approval_date: 2020-05-18
  device: Lyra Direct SARS-CoV-2 Assay
  entity: Quidel Corporation
  last_update: 2020-05-18
  links:
  - href: https://www.fda.gov/media/138179/download
    title: Quidel Direct - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138177/download
    title: Quidel Direct - Fact Sheet for Healthcare Provider
  - href: https://www.fda.gov/media/138180/download
    title: Quidel Direct - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138178/download
    title: Quidel Direct - Instruction for Use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-21
  device: P23 Labs TaqPath SARS-CoV-2 Assay
  entity: P23 Labs, LLC.
  last_update: 2020-07-10
  links:
  - href: https://www.fda.gov/media/138295/download
    title: P23 Labs Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138293/download
    title: P23 Labs Fact Sheet for Healthcare Provider
  - href: https://www.fda.gov/media/138296/download
    title: P23 Labs Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138294/download
    title: P23 Labs Instruction for Use (Home Collect 1)
  - href: https://www.fda.gov/media/140087/download
    title: 'P23 Labs TaqPath SARS-CoV-2 Assay - Instructions for Use (Home Collect
      2) '
    type: instructions for use
  - href: https://www.fda.gov/media/138297/download
    title: P23 Labs EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/139325/download
    title: P23 Labs TaqPath SARS-CoV-2 Assay - Letter Granting EUA Amendment(s) (June
      17, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection, Saliva
  type: diagnostic
- approval_date: 2020-05-21
  device: AQ-TOP COVID-19 Rapid Detection Kit
  entity: Seasun Biomaterials, Inc.
  last_update: 2020-05-21
  links:
  - href: https://www.fda.gov/media/138300/download
    title: Seasun AQ Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138298/download
    title: Seasun AQ Fact Sheet for Healthcare Provider
  - href: https://www.fda.gov/media/138301/download
    title: Seasun AQ Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138300/download
    title: Seasun AQ Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138307/download
    title: Seasun AQ Instruction for Use
  method: molecular
  settings:
  - H
  technology: RT-LAMP
  type: diagnostic
- approval_date: 2020-05-21
  device: DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit
  entity: SolGent Co., Ltd
  last_update: 2020-05-21
  links:
  - href: https://www.fda.gov/media/138306/download
    title: Solgent Diaplex Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138302/download
    title: Solgent Diaplex Fact Sheet for Healthcare Provider
  - href: https://www.fda.gov/media/138305/download
    title: Solgent Diaplex Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138303/download
    title: Solgent Diaplex Instruction for Use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-21
  device: BioCore 2019-nCoV Real Time PCR Kit
  entity: BioCore Co., Ltd.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/138292/download
    title: Biocore Cov Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138289/download
    title: Biocore Cov Fact Sheet for Healthcare Provider
  - href: https://www.fda.gov/media/138291/download
    title: Biocore Cov Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138290/download
    title: Biocore Cov Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-22
  device: Hymon SARS-CoV-2 Test Kit
  entity: dba SpectronRX
  last_update: 2020-08-11
  links:
  - href: https://www.fda.gov/media/138343/download
    title: Hymon SARS-CoV-2 Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138344/download
    title: Hymon SARS-CoV-2 Test Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138346/download
    title: Hymon SARS-CoV-2 Test Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138345/download
    title: Hymon SARS-CoV-2 Test Kit - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/141060/download
    title: dba SpectronRX Hymon SARS-CoV-2 Test Kit - Letter Granting EUA Revision(s)
      (August 11, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-28
  device: LetsGetChecked Coronavirus (COVID-19) Test
  entity: PrivaPath Diagnostics, Inc.
  last_update: 2020-08-14
  links:
  - href: https://www.fda.gov/media/138405/download
    title: PrivaPath Diagnostics, Inc. LetsGetChecked Coronavirus (COVID-19) Test
      - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138403/download
    title: PrivaPath Diagnostics, Inc. LetsGetChecked Coronavirus (COVID-19) Test
      - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138404/download
    title: PrivaPath Diagnostics, Inc. LetsGetChecked Coronavirus (COVID-19) Test
      - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138406/download
    title: PrivaPath Diagnostics, Inc. LetsGetChecked Coronavirus (COVID-19) Test
      - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/138407/download
    title: PrivaPath Diagnostics, Inc. LetsGetChecked Coronavirus (COVID-19) Test
      - IFU (Home Collect)
  - href: https://www.fda.gov/media/139784/download
    title: LetsGetChecked Coronavirus (COVID-19) Test - Letter Granting EUA Amendment(s)
      (July 6, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: TMA, chemiluminescent, Home Collection
  type: diagnostic
- approval_date: 2020-06-01
  device: Gravity Diagnostics COVID-19 Assay
  entity: Gravity Diagnostics, LLC
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/138532/download
    title: 'Gravity Dx Letter of Authorization '
    type: letter of authorization
  - href: https://www.fda.gov/media/138531/download
    title: Gravity Dx Fact Sheet for Healthcare Provider
  - href: https://www.fda.gov/media/138533/download
    title: Gravity Dx Factsheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138530/download
    title: Gravity DX EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/139668/download
    title: Gravity Diagnostics COVID-19 Assay - Letter Granting EUA Amendment(s) (June
      30, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection
  type: diagnostic
- approval_date: 2020-06-04
  device: Phosphorus COVID-19 RT-qPCR Test
  entity: Phosphorus Diagnostics LLC
  last_update: 2020-06-24
  links:
  - href: https://www.fda.gov/media/138652/download
    title: Phosphorus COVID-19 RT-qPCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138663/download
    title: Phosphorus COVID-19 RT-qPCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138653/download
    title: Phosphorus COVID-19 RT-qPCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138654/download
    title: Phosphorus COVID-19 RT-qPCR Test - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/138655/download
    title: Phosphorus COVID-19 RT-qPCR Test - IFU (Home Collect)
  - href: https://www.fda.gov/media/138656/download
    title: Phosphorus COVID-19 RT-qPCR Test - IFU (Clinic)
  - href: https://www.fda.gov/media/139508/download
    title: Phosphorus COVID-19 RT-qPCR Test - Letter Granting EUA Amendment(s) (June
      24, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection, Saliva
  type: diagnostic
- approval_date: 2020-06-05
  device: Genetron SARS-CoV-2 RNA Test
  entity: Genetron Health (Beijing) Co., Ltd.
  last_update: 2020-06-05
  links:
  - href: https://www.fda.gov/media/138682/download
    title: Genetron SARS-CoV-2 RNA Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138683/download
    title: Genetron SARS-CoV-2 RNA Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138684/download
    title: Genetron SARS-CoV-2 RNA Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138685/download
    title: Genetron SARS-CoV-2 RNA Test - IFU
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-08
  device: EURORealTime SARS-Cov-2
  entity: Euroimmun US, Inc.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/138758/download
    title: EURORealTime SARS-CoV-2 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138759/download
    title: EURORealTime SARS-CoV-2 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138760/download
    title: EURORealTime SARS-CoV-2 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138761/download
    title: EURORealTime SARS-CoV-2 - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-09
  device: Illumina COVIDSeq Test
  entity: Illumina, Inc.
  last_update: 2020-08-20
  links:
  - href: https://www.fda.gov/media/138778/download
    title: Illumina COVIDSeq Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138775/download
    title: Illumina COVIDSeq Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138777/download
    title: Illumina COVIDSeq Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138776/download
    title: Illumina COVIDSeq Test - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/141503/download
    title: Illumina COVIDSeq Test - Letter Granting EUA Revision(s) (August 20, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Sequencing
  type: diagnostic
- approval_date: 2020-06-09
  device: HDPCR SARS-CoV-2 Assay
  entity: ChromaCode Inc.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/138787/download
    title: HDPCR SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138785/download
    title: HDPCR SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138788/download
    title: HDPCR SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138786/download
    title: HDPCR SARS-CoV-2 Assay - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-10
  device: DTPM COVID-19 RT-PCR Test
  entity: Tide Laboratories, LLC
  last_update: 2020-06-10
  links:
  - href: https://www.fda.gov/media/138815/download
    title: DTPM COVID-19 RT-PCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138816/download
    title: DTPM COVID-19 RT-PCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138817/download
    title: DTPM COVID-19 RT-PCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138818/download
    title: DTPM COVID-19 RT-PCR Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-10
  device: ExProbe SARS-CoV-2 Testing Kit
  entity: TBG Biotechnology Corp.
  last_update: 2020-06-10
  links:
  - href: https://www.fda.gov/media/138819/download
    title: ExProbe SARS-CoV-2 Testing Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138820/download
    title: ExProbe SARS-CoV-2 Testing Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138821/download
    title: ExProbe SARS-CoV-2 Testing Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138822/download
    title: ExProbe SARS-CoV-2 Testing Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-10
  device: Cue COVID-19 Test
  entity: Cue Health Inc.
  last_update: 2020-08-20
  links:
  - href: https://www.fda.gov/media/138823/download
    title: Cue COVID-19 Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138824/download
    title: Cue COVID-19 Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138825/download
    title: Cue COVID-19 Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138826/download
    title: Cue COVID-19 Test - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/141483/download
    title: Cue COVID-19 Test - Letter Granting EUA Revision(s) (August 20, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  - W
  technology: RT, Isothermal amplification
  type: diagnostic
- approval_date: 2020-06-12
  device: Diagnovital SARS-CoV-2 Real-Time PCR Kit
  entity: RTA Laboratories Biological Products Pharmaceutical and Machinery Industry
  last_update: 2020-06-12
  links:
  - href: https://www.fda.gov/media/138929/download
    title: Diagnovital SARS-CoV-2 Real-Time PCR Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138927/download
    title: Diagnovital SARS-CoV-2 Real-Time PCR Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138930/download
    title: Diagnovital SARS-CoV-2 Real-Time PCR Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138928/download
    title: Diagnovital SARS-CoV-2 Real-Time PCR Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-15
  device: BioCode SARS-CoV-2 Assay
  entity: Applied BioCode, Inc.
  last_update: 2020-06-15
  links:
  - href: https://www.fda.gov/media/139046/download
    title: BioCode SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139047/download
    title: BioCode SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139048/download
    title: BioCode SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139049/download
    title: BioCode SARS-CoV-2 Assay - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: RT-PCR
  type: diagnostic
- approval_date: 2020-06-13
  device: KPMAS COVID-19 Test
  entity: Kaiser Permanente Mid-Atlantic States
  last_update: 2020-09-09
  links:
  - href: https://www.fda.gov/media/139066/download
    title: KPMAS COVID-19 Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139068/download
    title: KPMAS COVID-19 Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139070/download
    title: KPMAS COVID-19 Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139067/download
    title: KPMAS COVID-19 Test - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/139069/download
    title: KPMAS COVID-19 Test - Instructions for Use (Home Collect)
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection, Screening
  type: diagnostic
- approval_date: 2020-06-18
  device: COVID-19 Coronavirus Real Time PCR Kit
  entity: Jiangsu Bioperfectus Technologies Co., Ltd.
  last_update: 2020-06-18
  links:
  - href: https://www.fda.gov/media/139284/download
    title: COVID-19 Coronavirus Real Time PCR Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139277/download
    title: COVID-19 Coronavirus Real Time PCR Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139278/download
    title: COVID-19 Coronavirus Real Time PCR Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139279/download
    title: COVID-19 Coronavirus Real Time PCR Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-17
  device: OSUWMC COVID-19 RT-PCR test
  entity: The Ohio State University Wexner Medical Center
  last_update: 2020-06-17
  links:
  - href: https://www.fda.gov/media/139285/download
    title: OSUWMC COVID-19 RT-PCR test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139286/download
    title: OSUWMC COVID-19 RT-PCR test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139287/download
    title: OSUWMC COVID-19 RT-PCR test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139288/download
    title: OSUWMC COVID-19 RT-PCR test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-17
  device: Omni COVID-19 Assay by RT-PCR
  entity: Omnipathology Solutions Medical Corporation
  last_update: 2020-06-17
  links:
  - href: https://www.fda.gov/media/139289/download
    title: Omni COVID-19 Assay by RT-PCR - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139290/download
    title: Omni COVID-19 Assay by RT-PCR - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139291/download
    title: Omni COVID-19 Assay by RT-PCR - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139292/download
    title: Omni COVID-19 Assay by RT-PCR - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- amendments:
  - 2020-07-21
  approval_date: 2020-06-18
  device: TRUPCR SARS-CoV-2 Kit
  entity: 3B Blackbio Biotech India Ltd., a subsidiary of Kilpest India Ltd.
  last_update: 2020-07-21
  links:
  - href: https://www.fda.gov/media/139293/download
    title: TRUPCR SARS-CoV-2 Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139294/download
    title: TRUPCR SARS-CoV-2 Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139295/download
    title: TRUPCR SARS-CoV-2 Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139296/download
    title: TRUPCR SARS-CoV-2 Kit - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/140357/download
    title: TRUPCR SARS-CoV-2 Kit - Amendment July 21, 2020
    type: amendment
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-23
  device: HealthQuest Esoterics TaqPath SARS-CoV-2 Assay
  entity: HealthQuest Esoterics
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/139449/download
    title: HealthQuest Esoterics TaqPath SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139435/download
    title: HealthQuest Esoterics TaqPath SARS-CoV-2 Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139436/download
    title: HealthQuest Esoterics TaqPath SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139434/download
    title: HealthQuest Esoterics TaqPath SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-23
  device: FRL SARS CoV-2 Test
  entity: University of Alabama at Birmingham Fungal Reference Lab
  last_update: 2020-06-23
  links:
  - href: https://www.fda.gov/media/139439/download
    title: FRL SARS CoV-2 Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139438/download
    title: FRL SARS CoV-2 Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139440/download
    title: FRL SARS CoV-2 Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139437/download
    title: FRL SARS CoV-2 Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-23
  device: GenePro SARS-CoV-2 Test
  entity: Gencurix, Inc.
  last_update: 2020-06-23
  links:
  - href: https://www.fda.gov/media/139443/download
    title: GenePro SARS-CoV-2 Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139441/download
    title: GenePro SARS-CoV-2 Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139445/download
    title: GenePro SARS-CoV-2 Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139442/download
    title: GenePro SARS-CoV-2 Test - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-24
  device: MD Anderson High-throughput SARS-CoV-2 RT-PCR Assay
  entity: University of Texas MD Anderson Cancer Center, Molecular Diagnostics Laboratory
  last_update: 2020-06-24
  links:
  - href: https://www.fda.gov/media/139509/download
    title: MD Anderson High-throughput SARS-CoV-2 RT-PCR Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139510/download
    title: MD Anderson High-throughput SARS-CoV-2 RT-PCR Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139511/download
    title: MD Anderson High-throughput SARS-CoV-2 RT-PCR Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139512/download
    title: MD Anderson High-throughput SARS-CoV-2 RT-PCR Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-25
  device: DSL COVID-19 Assay
  entity: Diagnostic Solutions Laboratory, LLC
  last_update: 2020-06-25
  links:
  - href: https://www.fda.gov/media/139513/download
    title: DSL COVID-19 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139514/download
    title: DSL COVID-19 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139515/download
    title: DSL COVID-19 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139516/download
    title: DSL COVID-19 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-25
  device: FastPlex Triplex SARS-CoV-2 detection kit (RT-Digital PCR)
  entity: PreciGenome LLC
  last_update: 2020-06-25
  links:
  - href: https://www.fda.gov/media/139524/download
    title: FastPlex Triplex SARS-CoV-2 detection kit (RT-Digital PCR) - Letter of
      Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139522/download
    title: FastPlex Triplex SARS-CoV-2 detection kit (RT-Digital PCR) - Fact Sheet
      for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139525/download
    title: FastPlex Triplex SARS-CoV-2 detection kit (RT-Digital PCR) - Fact Sheet
      for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139523/download
    title: FastPlex Triplex SARS-CoV-2 detection kit (RT-Digital PCR) - Instructions
      for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: RT-digital droplet PCR
  type: diagnostic
- approval_date: 2020-06-25
  device: IntelliPlex SARS-CoV-2 Detection Kit
  entity: PlexBio Co., Ltd.
  last_update: 2020-06-25
  links:
  - href: https://www.fda.gov/media/139528/download
    title: IntelliPlex SARS-CoV-2 Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139526/download
    title: IntelliPlex SARS-CoV-2 Detection Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139529/download
    title: IntelliPlex SARS-CoV-2 Detection Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139527/download
    title: IntelliPlex SARS-CoV-2 Detection Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: RT-PCR
  type: diagnostic
- approval_date: 2020-06-26
  device: Inform Diagnostics SARS-CoV-2 RT-PCR Assay
  entity: Inform Diagnostics, Inc.
  last_update: 2020-06-26
  links:
  - href: https://www.fda.gov/media/139569/download
    title: Inform Diagnostics SARS-CoV-2 RT-PCR Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139570/download
    title: Inform Diagnostics SARS-CoV-2 RT-PCR Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139571/download
    title: Inform Diagnostics SARS-CoV-2 RT-PCR Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139572/download
    title: Inform Diagnostics SARS-CoV-2 RT-PCR Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-29
  device: LifeHope 2019-nCoV Real-Time RT-PCR Diagnostic Panel
  entity: LifeHope Labs
  last_update: 2020-06-29
  links:
  - href: https://www.fda.gov/media/139620/download
    title: LifeHope 2019-nCoV Real-Time RT-PCR Diagnostic Panel - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139621/download
    title: LifeHope 2019-nCoV Real-Time RT-PCR Diagnostic Panel - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139622/download
    title: LifeHope 2019-nCoV Real-Time RT-PCR Diagnostic Panel - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139623/download
    title: LifeHope 2019-nCoV Real-Time RT-PCR Diagnostic Panel - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-29
  device: Acupath COVID-19 Real-Time (RT-PCR) Assay
  entity: Acupath Laboratories, Inc.
  last_update: 2020-09-24
  links:
  - href: https://www.fda.gov/media/139669/download
    title: Acupath COVID-19 Real-Time (RT-PCR) Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139670/download
    title: Acupath COVID-19 Real-Time (RT-PCR) Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139671/download
    title: Acupath COVID-19 Real-Time (RT-PCR) Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139672/download
    title: Acupath COVID-19 Real-Time (RT-PCR) Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-30
  device: Psoma COVID-19 RT Test
  entity: Psomagen, Inc.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/139673/download
    title: Psomagen, Inc. Psoma COVID-19 RT Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139674/download
    title: Psomagen, Inc. Psoma COVID-19 RT Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139675/download
    title: Psomagen, Inc. Psoma COVID-19 RT Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139676/download
    title: Psomagen, Inc. Psoma COVID-19 RT Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-06-30
  device: COVID-19 RT-PCR Peptide Nucleic Acid (PNA) kit
  entity: TNS Co., Ltd (Bio TNS)
  last_update: 2020-06-30
  links:
  - href: https://www.fda.gov/media/139677/download
    title: Bio TNS COVID-19 RT-PCR Peptide Nucleic Acid (PNA) kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139678/download
    title: Bio TNS COVID-19 RT-PCR Peptide Nucleic Acid (PNA) kit - Fact Sheet for
      Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139679/download
    title: Bio TNS COVID-19 RT-PCR Peptide Nucleic Acid (PNA) kit - Fact Sheet for
      Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139680/download
    title: Bio TNS COVID-19 RT-PCR Peptide Nucleic Acid (PNA) kit - IFU
  method: molecular
  settings:
  - H
  technology: RT-PCR
  type: diagnostic
- approval_date: 2020-06-30
  device: Kroger Health COVID-19 Test Home Collection Kit
  entity: The Kroger Co.
  last_update: 2020-06-30
  links:
  - href: https://www.fda.gov/media/139681/download
    title: Kroger Health COVID-19 Test Home Collection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139682/download
    title: Kroger Health COVID-19 Test Home Collection Kit - IFU
  - href: https://www.fda.gov/media/139683/download
    title: Kroger Health COVID-19 Test Home Collection Kit - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - ''
  technology: Home Collection Kit
  type: diagnostic
- approval_date: 2020-07-01
  device: CentoFast-SARS-CoV-2 RT-PCR Assay
  entity: CENTOGENE US, LLC
  last_update: 2020-07-01
  links:
  - href: https://www.fda.gov/media/139722/download
    title: CentoFast-SARS-CoV-2 RT-PCR Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139723/download
    title: CentoFast-SARS-CoV-2 RT-PCR Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139724/download
    title: CentoFast-SARS-CoV-2 RT-PCR Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139725/download
    title: CentoFast-SARS-CoV-2 RT-PCR Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-02
  device: Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
  entity: Centers for Disease Control and Prevention (CDC)
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/139744/download
    title: Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139742/download
    title: Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139745/download
    title: Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139743/download
    title: Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Multi-analyte
  type: diagnostic
- approval_date: 2020-07-06
  device: Laboratorio Clinico Toledo SARS-CoV-2 Assay
  entity: Laboratorio Clinico Toledo
  last_update: 2020-07-06
  links:
  - href: https://www.fda.gov/media/139785/download
    title: Laboratorio Clinico Toledo SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139786/download
    title: Laboratorio Clinico Toledo SARS-CoV-2 Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139787/download
    title: Laboratorio Clinico Toledo SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139788/download
    title: Laboratorio Clinico Toledo SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-07
  device: AMPIPROBE SARS-CoV-2 Test System
  entity: Enzo Life Sciences, Inc.
  last_update: 2020-07-07
  links:
  - href: https://www.fda.gov/media/139829/download
    title: AMPIPROBE SARS-CoV-2 Test System - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139827/download
    title: AMPIPROBE SARS-CoV-2 Test System - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139830/download
    title: AMPIPROBE SARS-CoV-2 Test System - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139828/download
    title: AMPIPROBE SARS-CoV-2 Test System - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-07
  device: CareStart COVID-19 MDx RT-PCR
  entity: Access Bio, Inc.
  last_update: 2020-07-07
  links:
  - href: https://www.fda.gov/media/139833/download
    title: CareStart COVID-19 MDx RT-PCR - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139831/download
    title: CareStart COVID-19 MDx RT-PCR - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139834/download
    title: CareStart COVID-19 MDx RT-PCR - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139832/download
    title: CareStart COVID-19 MDx RT-PCR - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-07
  device: Gene By Gene SARS-CoV-2 Detection Test
  entity: Gene By Gene
  last_update: 2020-07-07
  links:
  - href: https://www.fda.gov/media/139838/download
    title: Gene By Gene SARS-CoV-2 Detection Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139837/download
    title: Gene By Gene SARS-CoV-2 Detection Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139839/download
    title: Gene By Gene SARS-CoV-2 Detection Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139836/download
    title: Gene By Gene SARS-CoV-2 Detection Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-08
  device: CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay
  entity: Clinical Research Sequencing Platform (CRSP), LLC at the Broad Institute
    of MIT and Harvard
  last_update: 2020-08-31
  links:
  - href: https://www.fda.gov/media/139860/download
    title: CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay
      - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139859/download
    title: CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay
      - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139861/download
    title: CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay
      - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139858/download
    title: CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay
      - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/141750/download
    title: CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay
      - Letter Granting EUA Revision(s) (August 28, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-09
  device: SARS-CoV-2 RNA DETECTR Assay
  entity: UCSF Health Clinical Laboratories, UCSF Clinical Labs at China Basin
  last_update: 2020-07-09
  links:
  - href: https://www.fda.gov/media/139934/download
    title: UCSF SARS-CoV-2 RNA DETECTR Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139935/download
    title: UCSF SARS-CoV-2 RNA DETECTR Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139936/download
    title: UCSF SARS-CoV-2 RNA DETECTR Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139937/download
    title: UCSF SARS-CoV-2 RNA DETECTR Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: RT-LAMP
  type: diagnostic
- approval_date: 2020-07-09
  device: Real-Q 2019-nCoV Detection Kit
  entity: BioSewoom, Inc.
  last_update: 2020-07-09
  links:
  - href: https://www.fda.gov/media/139938/download
    title: Real-Q 2019-nCoV Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139939/download
    title: Real-Q 2019-nCoV Detection Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139940/download
    title: Real-Q 2019-nCoV Detection Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139941/download
    title: Real-Q 2019-nCoV Detection Kit - IFU
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-10
  device: BMC-CReM COVID-19 Test
  entity: Boston Medical Center
  last_update: 2020-07-10
  links:
  - href: https://www.fda.gov/media/140024/download
    title: BMC-CReM COVID-19 Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140008/download
    title: BMC-CReM COVID-19 Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140026/download
    title: BMC-CReM COVID-19 Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140007/download
    title: BMC-CReM COVID-19 Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-13
  device: PowerChek 2019-nCoV Real-time PCR Kit
  entity: KogeneBiotech Co., Ltd.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/140066/download
    title: PowerChek 2019-nCoV Real-time PCR Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140067/download
    title: PowerChek 2019-nCoV Real-time PCR Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140068/download
    title: PowerChek 2019-nCoV Real-time PCR Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140069/download
    title: PowerChek 2019-nCoV Real-time PCR Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-13
  device: PhoenixDx SARS-CoV-2 Multiplex
  entity: Trax Management Services Inc.
  last_update: 2020-08-08
  links:
  - href: https://www.fda.gov/media/140070/download
    title: PhoenixDx SARS-CoV-2 Multiplex - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140071/download
    title: PhoenixDx SARS-CoV-2 Multiplex - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140072/download
    title: PhoenixDx SARS-CoV-2 Multiplex - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140073/download
    title: PhoenixDx SARS-CoV-2 Multiplex - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/140983/download
    title: PhoenixDx SARS-CoV-2 Multiplex - Letter Granting EUA Amendment(s) (August
      8, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-13
  device: Compass Laboratory Services SARS-CoV2 Assay
  entity: Compass Laboratory Services, LLC
  last_update: 2020-07-13
  links:
  - href: https://www.fda.gov/media/140074/download
    title: Compass Laboratory Services SARS-CoV2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140076/download
    title: Compass Laboratory Services SARS-CoV2 Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140077/download
    title: Compass Laboratory Services SARS-CoV2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140078/download
    title: Compass Laboratory Services SARS-CoV2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection
  type: diagnostic
- approval_date: 2020-07-15
  device: Quest Diagnostics PF SARS-CoV-2 Assay
  entity: Quest Diagnostics Infectious Disease, Inc.
  last_update: 2020-08-21
  links:
  - href: https://www.fda.gov/media/140226/download
    title: Quest Diagnostics PF SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140227/download
    title: Quest Diagnostics PF SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140228/download
    title: Quest Diagnostics PF SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140229/download
    title: Quest Diagnostics PF SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/140230/download
    title: Quest Diagnostics PF SARS-CoV-2 Assay - Instructions for Use (Home Collect)
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection
  type: diagnostic
- approval_date: 2020-07-15
  device: Quest Diagnostics RC SARS-CoV-2 Assay
  entity: Quest Diagnostics Infectious Disease, Inc.
  last_update: 2020-08-21
  links:
  - href: https://www.fda.gov/media/140231/download
    title: Quest Diagnostics RC SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140232/download
    title: Quest Diagnostics RC SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140233/download
    title: Quest Diagnostics RC SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140234/download
    title: Quest Diagnostics RC SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/140235/download
    title: Quest Diagnostics RC SARS-CoV-2 Assay - Instructions for Use (Home Collect)
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection
  type: diagnostic
- approval_date: 2020-07-15
  device: Quest Diagnostics HA SARS-CoV-2 Assay
  entity: Quest Diagnostics Infectious Disease, Inc.
  last_update: 2020-08-21
  links:
  - href: https://www.fda.gov/media/140236/download
    title: Quest Diagnostics HA SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140237/download
    title: Quest Diagnostics HA SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140238/download
    title: Quest Diagnostics HA SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140239/download
    title: Quest Diagnostics HA SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/140240/download
    title: Quest Diagnostics HA SARS-CoV-2 Assay - Instructions for Use (Home Collect)
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: TMA, chemiluminescent, Home Collection
  type: diagnostic
- amendments:
  - 2020-09-02
  approval_date: 2020-07-16
  device: Boston Heart COVID-19 RT-PCR Test
  entity: Boston Heart Diagnostics
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/140261/download
    title: Boston Heart COVID-19 RT-PCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140260/download
    title: Boston Heart COVID-19 RT-PCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140262/download
    title: Boston Heart COVID-19 RT-PCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140259/download
    title: Boston Heart COVID-19 RT-PCR Test - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/141827/download
    title: Boston Heart COVID-19 RT-PCR Test - Amendment - September 2, 2020
    type: amendment
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-17
  device: OraRisk COVID-19 RT-PCR
  entity: Access Genetics, LLC
  last_update: 2020-09-25
  links:
  - href: https://www.fda.gov/media/140290/download
    title: OraRisk COVID-19 RT-PCR - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140291/download
    title: OraRisk COVID-19 RT-PCR - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140292/download
    title: OraRisk COVID-19 RT-PCR - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140293/download
    title: OraRisk COVID-19 RT-PCR - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-21
  device: QuantiVirus SARS-CoV-2 Multiplex Test Kit
  entity: DiaCarta, Inc.
  last_update: 2020-07-21
  links:
  - href: https://www.fda.gov/media/140355/download
    title: QuantiVirus SARS-CoV-2 Multiplex Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140353/download
    title: QuantiVirus SARS-CoV-2 Multiplex Test Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140356/download
    title: QuantiVirus SARS-CoV-2 Multiplex Test Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140354/download
    title: QuantiVirus SARS-CoV-2 Multiplex Test Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-23
  device: Helix COVID-19 Test
  entity: Helix OpCo LLC (dba Helix)
  last_update: 2020-07-23
  links:
  - href: https://www.fda.gov/media/140422/download
    title: Helix COVID-19 Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140421/download
    title: Helix COVID-19 Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140423/download
    title: Helix COVID-19 Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140420/download
    title: Helix COVID-19 Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-24
  device: Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence
    Probing)
  entity: Jiangsu CoWin Biotech Co., Ltd.
  last_update: 2020-07-24
  links:
  - href: https://www.fda.gov/media/140426/download
    title: Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence
      Probing) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140424/download
    title: Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence
      Probing) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140427/download
    title: Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence
      Probing) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140425/download
    title: Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence
      Probing) - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-05-18
  device: Color Genomics SARS-CoV-2 RT-LAMP Diagnostic Assay
  entity: Color Genomics, Inc.
  last_update: 2020-09-22
  links:
  - href: https://www.fda.gov/media/138248/download
    title: Color SARS Cov-2 Diagnostic Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140448/download
    title: Color Genomics SARS-CoV-2 RT-LAMP Diagnostic Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140449/download
    title: Color Genomics SARS-CoV-2 RT-LAMP Diagnostic Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138249/download
    title: Color Genomics SARS-CoV-2 RT-LAMP Diagnostic Assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/140450/download
    title: Color SARS Cov-2 Diagnostic Assay - Instructions for Use (Home Collect)
    type: instructions for use
  - href: https://www.fda.gov/media/140451/download
    title: Color SARS Cov-2 Diagnostic Assay - Instructions for Use (On-site Collect)
    type: instructions for use
  - href: https://www.fda.gov/media/141672/download
    title: Color Genomics SARS-CoV-2 RT-LAMP Diagnostic Assay - Letter Granting EUA
      Revision(s) (August 28, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: RT, LAMP, Home Collection
  type: diagnostic
- approval_date: 2020-07-27
  device: Lilly SARS-CoV-2 Assay
  entity: Eli Lilly and Company
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/140540/download
    title: Lilly SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140541/download
    title: Lilly SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140542/download
    title: Lilly SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140543/download
    title: Lilly SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/142364/download
    title: Lilly SARS-CoV-2 Assay - Letter Granting EUA Revision(s) (September 21,
      2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2019-10-01
  device: SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic Assay
  entity: Sandia National Laboratories
  last_update: 2020-07-27
  links:
  - href: https://www.fda.gov/media/140544/download
    title: SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140545/download
    title: SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140546/download
    title: SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140547/download
    title: SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-30
  device: CRL Rapid Response
  entity: Clinical Reference Laboratory, Inc.
  last_update: 2020-07-30
  links:
  - href: https://www.fda.gov/media/140664/download
    title: CRL Rapid Response - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140662/download
    title: CRL Rapid Response - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140665/download
    title: CRL Rapid Response - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140661/download
    title: CRL Rapid Response - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/140663/download
    title: CRL Rapid Response - Instructions for Use (Home Collect)
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection, Saliva
  type: diagnostic
- approval_date: 2020-07-31
  device: SARS-CoV-2 Test Kit (Real-time PCR)
  entity: Xiamen Zeesan Biotech Co., Ltd.
  last_update: 2020-07-31
  links:
  - href: https://www.fda.gov/media/140718/download
    title: SARS-CoV-2 Test Kit (Real-time PCR) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140716/download
    title: SARS-CoV-2 Test Kit (Real-time PCR) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140719/download
    title: SARS-CoV-2 Test Kit (Real-time PCR) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140717/download
    title: SARS-CoV-2 Test Kit (Real-time PCR) - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-07-31
  device: UCSD RC SARS-CoV-2 Assay
  entity: University of California San Diego Health
  last_update: 2020-07-31
  links:
  - href: https://www.fda.gov/media/140714/download
    title: UCSD RC SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140713/download
    title: UCSD RC SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140715/download
    title: UCSD RC SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140712/download
    title: UCSD RC SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Pooling
  type: diagnostic
- approval_date: 2020-08-03
  device: Wren Laboratories COVID-19 PCR Test
  entity: Wren Laboratories LLC
  last_update: 2020-08-03
  links:
  - href: https://www.fda.gov/media/140773/download
    title: Wren Laboratories COVID-19 PCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140774/download
    title: Wren Laboratories COVID-19 PCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140775/download
    title: Wren Laboratories COVID-19 PCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140776/download
    title: Wren Laboratories COVID-19 PCR Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-03
  device: Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay
  entity: Ethos Laboratories
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/140777/download
    title: Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140778/download
    title: Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140779/download
    title: Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140780/download
    title: Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/140781/download
    title: Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay - Information for Use
  - href: https://www.fda.gov/media/141058/download
    title: Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay - Letter Granting EUA Revision(s)
      (August 11, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/142305/download
    title: Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay - Letter Granting EUA Revision(s)
      (September 18, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: RT-PCR and MALDI-TOF Mass Spec.
  type: diagnostic
- approval_date: 2020-08-03
  device: Cleveland Clinic SARS-CoV-2 Assay
  entity: Cleveland Clinic Robert J. Tomsich Pathology and Laboratory Medicine Institute
  last_update: 2020-08-03
  links:
  - href: https://www.fda.gov/media/140785/download
    title: Cleveland Clinic SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140786/download
    title: Cleveland Clinic SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140787/download
    title: Cleveland Clinic SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140788/download
    title: Cleveland Clinic SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-03
  device: Poplar SARS-CoV-2 TMA Pooling assay
  entity: Poplar Healthcare
  last_update: 2020-08-03
  links:
  - href: https://www.fda.gov/media/140789/download
    title: Poplar SARS-CoV-2 TMA Pooling assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140790/download
    title: Poplar SARS-CoV-2 TMA Pooling assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140791/download
    title: Poplar SARS-CoV-2 TMA Pooling assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140792/download
    title: Poplar SARS-CoV-2 TMA Pooling assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: TMA, chemiluminescent, Pooling
  type: diagnostic
- approval_date: 2020-05-22
  device: SARS-CoV-2 (N gene detection) Test
  entity: Exact Sciences Laboratories
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/138327/download
    title: Exact Sciences SARS-CoV-2 (N gene detection) Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140794/download
    title: SARS-CoV-2 (N gene detection) Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140795/download
    title: SARS-CoV-2 (N gene detection) Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138328/download
    title: Exact Sciences SARS-CoV-2 (N gene detection) Test - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/141674/download
    title: SARS-CoV-2 (N gene detection) Test - IFU (Home Collect)
  - href: https://www.fda.gov/media/141671/download
    title: SARS-CoV-2 (N gene detection) Test - Letter Granting EUA Revision(s) (August
      28, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection
  type: diagnostic
- approval_date: 2020-08-03
  device: Genus SARS-CoV-2 Assay
  entity: ISPM Labs, LLC dba Capstone Healthcare
  last_update: 2020-08-03
  links:
  - href: https://www.fda.gov/media/140815/download
    title: Genus SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140816/download
    title: Genus SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140817/download
    title: Genus SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140818/download
    title: Genus SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-06
  device: Helix COVID-19 NGS Test
  entity: Helix OpCo LLC (dba Helix)
  last_update: 2020-08-06
  links:
  - href: https://www.fda.gov/media/140914/download
    title: Helix COVID-19 NGS Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140915/download
    title: Helix COVID-19 NGS Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140916/download
    title: Helix COVID-19 NGS Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140917/download
    title: Helix COVID-19 NGS Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Sequencing
  type: diagnostic
- approval_date: 2020-08-05
  device: ViroKey SARS-CoV-2 RT-PCR Test
  entity: Vela Operations Singapore Pte Ltd
  last_update: 2020-08-05
  links:
  - href: https://www.fda.gov/media/140919/download
    title: ViroKey SARS-CoV-2 RT-PCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140920/download
    title: ViroKey SARS-CoV-2 RT-PCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140921/download
    title: ViroKey SARS-CoV-2 RT-PCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140922/download
    title: ViroKey SARS-CoV-2 RT-PCR Test - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-07
  device: GWU SARS-CoV-2 RT-PCR Test
  entity: George Washington University Public Health Laboratory
  last_update: 2020-08-07
  links:
  - href: https://www.fda.gov/media/140977/download
    title: GWU SARS-CoV-2 RT-PCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140978/download
    title: GWU SARS-CoV-2 RT-PCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140979/download
    title: GWU SARS-CoV-2 RT-PCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/140980/download
    title: GWU SARS-CoV-2 RT-PCR Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-10
  device: Solaris Multiplex SARS-CoV-2 Assay
  entity: Solaris Diagnostics
  last_update: 2020-08-10
  links:
  - href: https://www.fda.gov/media/141013/download
    title: Solaris Multiplex SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141014/download
    title: Solaris Multiplex SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141015/download
    title: Solaris Multiplex SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141016/download
    title: Solaris Multiplex SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-10
  device: Alpha Genomix TaqPath SARS-CoV-2 Combo Assay
  entity: Alpha Genomix Laboratories
  last_update: 2020-08-10
  links:
  - href: https://www.fda.gov/media/141017/download
    title: Alpha Genomix TaqPath SARS-CoV-2 Combo Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141019/download
    title: Alpha Genomix TaqPath SARS-CoV-2 Combo Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141020/download
    title: Alpha Genomix TaqPath SARS-CoV-2 Combo Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141021/download
    title: Alpha Genomix TaqPath SARS-CoV-2 Combo Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-11
  device: Biomeme SARS-CoV-2 Real-Time RT-PCR Test
  entity: Biomeme, Inc.
  last_update: 2020-08-11
  links:
  - href: https://www.fda.gov/media/141049/download
    title: Biomeme SARS-CoV-2 Real-Time RT-PCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141050/download
    title: Biomeme SARS-CoV-2 Real-Time RT-PCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141051/download
    title: Biomeme SARS-CoV-2 Real-Time RT-PCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141052/download
    title: Biomeme SARS-CoV-2 Real-Time RT-PCR Test - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-11
  device: LumiraDx SARS-CoV-2 RNA STAR
  entity: LumiraDx UK Ltd.
  last_update: 2020-08-11
  links:
  - href: https://www.fda.gov/media/141054/download
    title: LumiraDx SARS-CoV-2 RNA STAR - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141055/download
    title: LumiraDx SARS-CoV-2 RNA STAR - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141056/download
    title: LumiraDx SARS-CoV-2 RNA STAR - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141057/download
    title: LumiraDx SARS-CoV-2 RNA STAR - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: RT, non-isothermal nucleic acid amplification qSTAR
  type: diagnostic
- approval_date: 2020-08-13
  device: Pro-AmpRT SARS-CoV-2 Test
  entity: Pro-Lab Diagnostics
  last_update: 2020-08-13
  links:
  - href: https://www.fda.gov/media/141146/download
    title: Pro-AmpRT SARS-CoV-2 Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141147/download
    title: Pro-AmpRT SARS-CoV-2 Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141148/download
    title: Pro-AmpRT SARS-CoV-2 Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141149/download
    title: Pro-AmpRT SARS-CoV-2 Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: RT, Isothermal amplification
  type: diagnostic
- approval_date: 2020-08-15
  device: SalivaDirect
  entity: Yale School of Public Health, Department of Epidemiology of Microbial Diseases
  last_update: 2020-08-28
  links:
  - href: https://www.fda.gov/media/141194/download
    title: SalivaDirect - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141193/download
    title: SalivaDirect - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141195/download
    title: SalivaDirect - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141192/download
    title: SalivaDirect - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/141537/download
    title: SalivaDirect - Letter Granting EUA Revision(s) (August 25, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Saliva
  type: diagnostic
- approval_date: 2020-08-17
  device: COVID-19 Nucleic Acid RT-PCR Test Kit
  entity: ZhuHai Sinochips Bioscience Co., Ltd.
  last_update: 2020-08-17
  links:
  - href: https://www.fda.gov/media/141243/download
    title: COVID-19 Nucleic Acid RT-PCR Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141244/download
    title: COVID-19 Nucleic Acid RT-PCR Test Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141245/download
    title: COVID-19 Nucleic Acid RT-PCR Test Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141246/download
    title: COVID-19 Nucleic Acid RT-PCR Test Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-21
  device: Guardant-19
  entity: Guardant Health, Inc.
  last_update: 2020-08-21
  links:
  - href: https://www.fda.gov/media/141484/download
    title: Guardant-19 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141485/download
    title: Guardant-19 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141486/download
    title: Guardant-19 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141487/download
    title: Guardant-19 - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Sequencing
  type: diagnostic
- approval_date: 2020-08-21
  device: DxTerity SARS-CoV-2 RT-PCR Test
  entity: DxTerity Diagnostics, Inc.
  last_update: 2020-08-21
  links:
  - href: https://www.fda.gov/media/141488/download
    title: DxTerity SARS-CoV-2 RT-PCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141489/download
    title: DxTerity SARS-CoV-2 RT-PCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141490/download
    title: DxTerity SARS-CoV-2 RT-PCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141491/download
    title: DxTerity SARS-CoV-2 RT-PCR Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Saliva
  type: diagnostic
- approval_date: 2020-08-21
  device: Texas Department of State Health Services (DSHS) SARS-CoV-2 Assay
  entity: Texas Department of State Health Services, Laboratory Services Section
  last_update: 2020-08-21
  links:
  - href: https://www.fda.gov/media/141493/download
    title: Texas Department of State Health Services (DSHS) SARS-CoV-2 Assay - Letter
      of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141494/download
    title: Texas Department of State Health Services (DSHS) SARS-CoV-2 Assay - Fact
      Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141495/download
    title: Texas Department of State Health Services (DSHS) SARS-CoV-2 Assay - Fact
      Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141496/download
    title: Texas Department of State Health Services (DSHS) SARS-CoV-2 Assay - EUA
      Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-25
  device: Advanta Dx SARS-CoV-2 RT-PCR Assay
  entity: Fluidigm Corporation
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/141538/download
    title: Advanta Dx SARS-CoV-2 RT-PCR Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141539/download
    title: Advanta Dx SARS-CoV-2 RT-PCR Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141540/download
    title: Advanta Dx SARS-CoV-2 RT-PCR Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141541/download
    title: Advanta Dx SARS-CoV-2 RT-PCR Assay - IFU
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Saliva
  type: diagnostic
- approval_date: 2020-08-25
  device: QDX SARS-CoV-2 Assay
  entity: QDx Pathology Services
  last_update: 2020-08-25
  links:
  - href: https://www.fda.gov/media/141542/download
    title: QDX SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141543/download
    title: QDX SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141544/download
    title: QDX SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141545/download
    title: QDX SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/141546/download
    title: QDX SARS-CoV-2 Assay - IFU (Home Collect)
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection
  type: diagnostic
- approval_date: 2020-08-26
  device: Cuur Diagnostics SARS-CoV-2 Molecular Assay
  entity: Cuur Diagnostics
  last_update: 2020-08-26
  links:
  - href: https://www.fda.gov/media/141624/download
    title: Cuur Diagnostics SARS-CoV-2 Molecular Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141625/download
    title: Cuur Diagnostics SARS-CoV-2 Molecular Assay - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141626/download
    title: Cuur Diagnostics SARS-CoV-2 Molecular Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141627/download
    title: Cuur Diagnostics SARS-CoV-2 Molecular Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-28
  device: PCL SARS-CoV-2 Real-Time RT-PCR Assay
  entity: Patients Choice Laboratories, LLC
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/141662/download
    title: PCL SARS-CoV-2 Real-Time RT-PCR Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141663/download
    title: PCL SARS-CoV-2 Real-Time RT-PCR Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141664/download
    title: PCL SARS-CoV-2 Real-Time RT-PCR Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141665/download
    title: PCL SARS-CoV-2 Real-Time RT-PCR Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-28
  device: DxTerity SARS-CoV-2 RT PCR CE Test
  entity: DxTerity Diagnostics, Inc.
  last_update: 2020-08-28
  links:
  - href: https://www.fda.gov/media/141666/download
    title: DxTerity SARS-CoV-2 RT PCR CE Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141667/download
    title: DxTerity SARS-CoV-2 RT PCR CE Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141668/download
    title: DxTerity SARS-CoV-2 RT PCR CE Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141669/download
    title: DxTerity SARS-CoV-2 RT PCR CE Test - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/141670/download
    title: DxTerity SARS-CoV-2 RT PCR CE Test - IFU (Home Collect)
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Home Collection, Screening, Saliva
  type: diagnostic
- approval_date: 2020-08-31
  device: T2SARS-CoV-2 Panel
  entity: T2 Biosystems, Inc.
  last_update: 2020-08-31
  links:
  - href: https://www.fda.gov/media/141752/download
    title: T2SARS-CoV-2 Panel - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141753/download
    title: T2SARS-CoV-2 Panel - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141754/download
    title: T2SARS-CoV-2 Panel - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141755/download
    title: T2SARS-CoV-2 Panel - IFU
  method: molecular
  settings:
  - H
  technology: RT, amplification, T2 Magnetic resonance
  type: diagnostic
- approval_date: 2020-08-31
  device: MiraDx SARS-CoV-2 RT-PCR assay
  entity: MiraDx
  last_update: 2020-08-31
  links:
  - href: https://www.fda.gov/media/141756/download
    title: MiraDx SARS-CoV-2 RT-PCR assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141757/download
    title: MiraDx SARS-CoV-2 RT-PCR assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141758/download
    title: MiraDx SARS-CoV-2 RT-PCR assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141760/download
    title: MiraDx SARS-CoV-2 RT-PCR assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-31
  device: SARS-CoV-2 DETECTR Reagent Kit
  entity: Mammoth Biosciences, Inc.
  last_update: 2020-08-31
  links:
  - href: https://www.fda.gov/media/141762/download
    title: SARS-CoV-2 DETECTR Reagent Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141763/download
    title: SARS-CoV-2 DETECTR Reagent Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141764/download
    title: SARS-CoV-2 DETECTR Reagent Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141765/download
    title: SARS-CoV-2 DETECTR Reagent Kit - IFU
  method: molecular
  settings:
  - H
  technology: RT-LAMP, CRISPR
  type: diagnostic
- approval_date: 2020-08-31
  device: BayCare SARS-CoV-2 RT PCR Assay
  entity: BayCare Laboratories, LLC
  last_update: 2020-08-31
  links:
  - href: https://www.fda.gov/media/141766/download
    title: BayCare SARS-CoV-2 RT PCR Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141767/download
    title: BayCare SARS-CoV-2 RT PCR Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141768/download
    title: BayCare SARS-CoV-2 RT PCR Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141769/download
    title: BayCare SARS-CoV-2 RT PCR Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Pooling
  type: diagnostic
- approval_date: 2020-09-01
  device: MobileDetect Bio BCC19 (MD-Bio BCC19) Test Kit
  entity: Detectachem Inc.
  last_update: 2020-10-02
  links:
  - href: https://www.fda.gov/media/141788/download
    title: MobileDetect Bio BCC19 (MD-Bio BCC19) Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141789/download
    title: MobileDetect Bio BCC19 (MD-Bio BCC19) Test Kit - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141790/download
    title: MobileDetect Bio BCC19 (MD-Bio BCC19) Test Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141791/download
    title: MobileDetect Bio BCC19 (MD-Bio BCC19) Test Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  - M
  technology: RT-LAMP
  technologies:
    - RT-LAMP
  type: diagnostic
- approval_date: 2020-09-01
  device: Kaira 2019-nCoV Detection Kit
  entity: OPTOLANE Technologies, Inc.
  last_update: 2020-09-01
  links:
  - href: https://www.fda.gov/media/141792/download
    title: Kaira 2019-nCoV Detection Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141793/download
    title: Kaira 2019-nCoV Detection Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141794/download
    title: Kaira 2019-nCoV Detection Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141795/download
    title: Kaira 2019-nCoV Detection Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-08-31
  device: Color COVID-19 Self-Swab Collection Kit
  entity: Color Genomics, Inc.
  last_update: 2020-09-15
  links:
  - href: https://www.fda.gov/media/141796/download
    title: Color COVID-19 Self-Swab Collection Kit- Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141797/download
    title: Color COVID-19 Self-Swab Collection Kit - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/141798/download
    title: Color COVID-19 Self-Swab Collection Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - ''
  technology: Home Collection Kit
  type: diagnostic
- approval_date: 2020-09-02
  device: Bio-Speedy Direct RT-qPCR SARS-CoV-2
  entity: Bioeksen R&D Technologies Ltd.
  last_update: 2020-09-02
  links:
  - href: https://www.fda.gov/media/141824/download
    title: Bio-Speedy Direct RT-qPCR SARS-CoV-2 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141822/download
    title: Bio-Speedy Direct RT-qPCR SARS-CoV-2 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141825/download
    title: Bio-Speedy Direct RT-qPCR SARS-CoV-2 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141823/download
    title: Bio-Speedy Direct RT-qPCR SARS-CoV-2 - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-09-03
  device: cobas SARS-CoV-2 & Influenza A/B
  entity: Roche Molecular Systems, Inc.
  last_update: 2020-09-03
  links:
  - href: https://www.fda.gov/media/141884/download
    title: cobas SARS-CoV-2 & Influenza A/B - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141885/download
    title: cobas SARS-CoV-2 & Influenza A/B - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141886/download
    title: cobas SARS-CoV-2 & Influenza A/B - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141887/download
    title: cobas SARS-CoV-2 & Influenza A/B - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  - M
  technology: Real-time RT-PCR, Multi-analyte
  type: diagnostic
- approval_date: 2020-09-04
  device: qSanger-COVID-19 Assay
  entity: BillionToOne, Inc.
  last_update: 2020-09-04
  links:
  - href: https://www.fda.gov/media/141932/download
    title: qSanger-COVID-19 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141933/download
    title: qSanger-COVID-19 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141934/download
    title: qSanger-COVID-19 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141935/download
    title: qSanger-COVID-19 Assay - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Sequencing
  type: diagnostic
- approval_date: 2020-09-08
  device: Verily COVID-19 RT-PCR Test
  entity: Verily Life Sciences
  last_update: 2020-09-08
  links:
  - href: https://www.fda.gov/media/141948/download
    title: Verily COVID-19 RT-PCR Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141949/download
    title: Verily COVID-19 RT-PCR Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141950/download
    title: Verily COVID-19 RT-PCR Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141951/download
    title: Verily COVID-19 RT-PCR Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Pooling
  type: diagnostic
- approval_date: 2020-09-09
  device: Wantai SARS-CoV-2 RT-PCR Kit
  entity: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  last_update: 2020-09-09
  links:
  - href: https://www.fda.gov/media/141994/download
    title: Wantai SARS-CoV-2 RT-PCR Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141995/download
    title: Wantai SARS-CoV-2 RT-PCR Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141996/download
    title: Wantai SARS-CoV-2 RT-PCR Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141997/download
    title: Wantai SARS-CoV-2 RT-PCR Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-09-14
  device: cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas
    Liat System
  entity: Roche Molecular Systems, Inc.
  last_update: 2020-09-18
  links:
  - href: https://www.fda.gov/media/142190/download
    title: cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas
      Liat System - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142191/download
    title: cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas
      Liat System - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142192/download
    title: cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas
      Liat System - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142193/download
    title: cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas
      Liat System - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/142441/download
    title: cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas
      Liat System - Letter Granting EUA Revision(s) (September 18, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  - M
  - W
  technology: Real-time RT-PCR, Multi-analyte
  type: diagnostic
- approval_date: 2020-09-16
  device: Visby Medical COVID-19
  entity: Visby Medical, Inc.
  last_update: 2020-09-16
  links:
  - href: https://www.fda.gov/media/142225/download
    title: Visby Medical COVID-19 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142226/download
    title: Visby Medical COVID-19 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142227/download
    title: Visby Medical COVID-19 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142228/download
    title: Visby Medical COVID-19 - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  - M
  technology: RT-PCR
  type: diagnostic
- approval_date: 2020-09-18
  device: GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT
  entity: GK Pharmaceuticals Contract Manufacturing Operations
  last_update: 2020-09-18
  links:
  - href: https://www.fda.gov/media/142307/download
    title: GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142308/download
    title: GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142309/download
    title: GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142310/download
    title: GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT - IFU
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-09-21
  device: KimForest SARS-CoV-2 Detection Kit v1
  entity: KimForest Enterprise Co., Ltd.
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/142360/download
    title: KimForest SARS-CoV-2 Detection Kit v1 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142361/download
    title: KimForest SARS-CoV-2 Detection Kit v1 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142362/download
    title: KimForest SARS-CoV-2 Detection Kit v1 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142363/download
    title: KimForest SARS-CoV-2 Detection Kit v1 - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-09-22
  device: Clarifi COVID-19 Test Kit
  entity: Quadrant Biosciences Inc.
  last_update: 2020-09-22
  links:
  - href: https://www.fda.gov/media/142376/download
    title: Clarifi COVID-19 Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142377/download
    title: Clarifi COVID-19 Test Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142378/download
    title: Clarifi COVID-19 Test Kit - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142379/download
    title: Clarifi COVID-19 Test Kit - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Saliva
  type: diagnostic
- approval_date: 2020-09-22
  device: ViroKey SARS-CoV-2 RT-PCR Test v2.0
  entity: Vela Operations Singapore Pte. Ltd.
  last_update: 2020-09-22
  links:
  - href: https://www.fda.gov/media/142380/download
    title: ViroKey SARS-CoV-2 RT-PCR Test v2.0 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142381/download
    title: ViroKey SARS-CoV-2 RT-PCR Test v2.0 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142382/download
    title: ViroKey SARS-CoV-2 RT-PCR Test v2.0 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142383/download
    title: ViroKey SARS-CoV-2 RT-PCR Test v2.0 - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-09-23
  device: Clear Dx SARS-CoV-2 Test
  entity: Clear Labs, Inc.
  last_update: 2020-09-23
  links:
  - href: https://www.fda.gov/media/142419/download
    title: Clear Dx SARS-CoV-2 Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142417/download
    title: Clear Dx SARS-CoV-2 Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142420/download
    title: Clear Dx SARS-CoV-2 Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142418/download
    title: Clear Dx SARS-CoV-2 Test - Instructions for Use
    type: instructions for use
  method: molecular
  settings:
  - H
  technology: RT-PCR and Sequencing
  type: diagnostic
- approval_date: 2020-09-24
  device: Xpert Xpress SARS-CoV-2/Flu/RSV
  entity: Cepheid
  last_update: 2020-09-24
  links:
  - href: https://www.fda.gov/media/142434/download
    title: Xpert Xpress SARS-CoV-2/Flu/RSV - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142435/download
    title: Xpert Xpress SARS-CoV-2/Flu/RSV - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142436/download
    title: Xpert Xpress SARS-CoV-2/Flu/RSV - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142437/download
    title: Xpert Xpress SARS-CoV-2/Flu/RSV - Instructions for Use for Labs
    type: instructions for use
  - href: https://www.fda.gov/media/142438/download
    title: Xpert Xpress SARS-CoV-2/Flu/RSV - Instructions for Point-of-Care
    type: instructions for use
  method: molecular
  settings:
  - H
  - M
  - W
  technology: Real-time RT-PCR, Multi-analyte
  type: diagnostic
- approval_date: 2020-09-25
  device: Genetrack SARS-CoV-2 Molecular Assay
  entity: Genetrack Biolabs, Inc.
  last_update: 2020-09-25
  links:
  - href: https://www.fda.gov/media/142479/download
    title: Genetrack SARS-CoV-2 Molecular Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142480/download
    title: Genetrack SARS-CoV-2 Molecular Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142481/download
    title: Genetrack SARS-CoV-2 Molecular Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142482/download
    title: Genetrack SARS-CoV-2 Molecular Assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/142601/download
    title: Genetrack SARS-CoV-2 Molecular Assay - IFU (Home Collect)
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-09-30
  device: Aeon Global Health SARS-CoV-2 Assay
  entity: Aeon Global Health
  last_update: 2020-09-30
  links:
  - href: https://www.fda.gov/media/142532/download
    title: Aeon Global Health SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142533/download
    title: Aeon Global Health SARS-CoV-2 Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142534/download
    title: Aeon Global Health SARS-CoV-2 Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142535/download
    title: Aeon Global Health SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-09-29
  device: CentoSure SARS-CoV-2 RT-PCR Assay
  entity: CENTOGENE US, LLC
  last_update: 2020-09-29
  links:
  - href: https://www.fda.gov/media/142536/download
    title: CentoSure SARS-CoV-2 RT-PCR Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142537/download
    title: CentoSure SARS-CoV-2 RT-PCR Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142538/download
    title: CentoSure SARS-CoV-2 RT-PCR Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142539/download
    title: CentoSure SARS-CoV-2 RT-PCR Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR, Screening
  type: diagnostic
- approval_date: 2020-09-29
  device: "Akron Children\u2019s Hospital SARS-CoV-2 Assay"
  entity: "Akron Children\u2019s Hospital"
  last_update: 2020-09-29
  links:
  - href: https://www.fda.gov/media/142540/download
    title: "Akron Children\u2019s Hospital SARS-CoV-2 Assay - Letter of Authorization"
    type: letter of authorization
  - href: https://www.fda.gov/media/142541/download
    title: "Akron Children\u2019s Hospital SARS-CoV-2 Assay - Fact Sheet for Healthcare\
      \ Providers"
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142542/download
    title: "Akron Children\u2019s Hospital SARS-CoV-2 Assay - Fact Sheet for Patients"
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142543/download
    title: "Akron Children\u2019s Hospital SARS-CoV-2 Assay - EUA Summary"
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-09-29
  device: SARS-CoV-2 MassArray Test
  entity: National Jewish Health
  last_update: 2020-09-29
  links:
  - href: https://www.fda.gov/media/142545/download
    title: SARS-CoV-2 MassArray Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142546/download
    title: SARS-CoV-2 MassArray Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142547/download
    title: SARS-CoV-2 MassArray Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142548/download
    title: SARS-CoV-2 MassArray Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: RT-PCR and MALDI-TOF Mass Spec.
  type: diagnostic
- approval_date: 2020-09-30
  device: Alimetrix SARS-CoV-2 RT-PCR Assay
  entity: Alimetrix, Inc.
  last_update: 2020-09-30
  links:
  - href: https://www.fda.gov/media/142589/download
    title: Alimetrix SARS-CoV-2 RT-PCR Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142590/download
    title: Alimetrix SARS-CoV-2 RT-PCR Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142591/download
    title: Alimetrix SARS-CoV-2 RT-PCR Assay - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142592/download
    title: Alimetrix SARS-CoV-2 RT-PCR Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: RT-PCR, Microarray Hybridization
  type: diagnostic
- approval_date: 2020-10-01
  device: iC SARS-CoV2 Test
  entity: Tempus Labs, Inc.
  last_update: 2020-10-01
  links:
  - href: https://www.fda.gov/media/142593/download
    title: iC SARS-CoV2 Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142594/download
    title: iC SARS-CoV2 Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142595/download
    title: iC SARS-CoV2 Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142596/download
    title: iC SARS-CoV2 Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  technology: Real-time RT-PCR
  type: diagnostic
- approval_date: 2020-04-30
  device: Altru Dx SARS-CoV-2 RT-PCR assay
  entity: Altru Diagnostics, Inc.
  last_update: 2020-06-04
  links:
  - href: https://www.fda.gov/media/137545/download
    title: Altru Dx SARS-CoV-2 RT-PCR assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137546/download
    title: Altru Dx SARS-CoV-2 RT-PCR assay - EUA Summary
    type: eua summary
  - href: https://www.fda.gov/media/138623/download
    title: Altru Dx SARS-CoV-2 Assay - Letter Granting EUA Amendment(s) (June 4, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-28
  device: SARS-CoV-2 Test
  entity: Biocerna
  last_update: 2020-04-28
  links:
  - href: https://www.fda.gov/media/137451/download
    title: BIOCERNA SARS Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137450/download
    title: Biocerna SARS EUA Summary Letter
    type: letter of authorization
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-27
  device: SARS-CoV-2 Assay
  entity: Nationwide Children's Hospital
  last_update: 2020-04-27
  links:
  - href: https://www.fda.gov/media/137424/download
    title: National Children's Hospital - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137423/download
    title: National Children's Hospital EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-22
  device: SARS-CoV-2 PCR Test
  entity: Diatherix Eurofins Laboratory
  last_update: 2020-09-22
  links:
  - href: https://www.fda.gov/media/137256/download
    title: Diatherix SARS Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137255/download
    title: Diatherix SARS EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2019-10-01
  device: Orig3n 2019 Novel Coronavirus (COVID-19) Test
  entity: Orig3n, Inc.
  last_update: 2020-04-10
  links:
  - href: https://www.fda.gov/media/136874/download
    title: Orig3n 2019 Novel Coronavirus (COVID-19) Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136873/download
    title: Orig3n 2019 Novel Coronavirus (COVID-19) Test - Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-10
  device: SDI SARS-CoV-2 Assay
  entity: Specialty Diagnostic (SDI) Laboratories
  last_update: 2020-04-10
  links:
  - href: https://www.fda.gov/media/136878/download
    title: SDI SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136877/download
    title: SDI SARS-CoV-2 Assay - Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-08
  device: Stanford SARS-CoV-2 assay
  entity: Stanford Health Care Clinical Virology Laboratory
  last_update: 2020-04-08
  links:
  - href: https://www.fda.gov/media/136817/download
    title: 'Stanford SARS-CoV-2 PCR Assay - Letter '
    type: letter of authorization
  - href: https://www.fda.gov/media/136818/download
    title: Stanford SARS - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-06
  device: Viracor SARS-CoV-2 assay
  entity: Viracor Eurofins Clinical Diagnostics
  last_update: 2020-04-06
  links:
  - href: https://www.fda.gov/media/136739/download
    title: Viracor SARS-CoV-2 Assay - Letter
    type: letter of authorization
  - href: https://www.fda.gov/media/136740/download
    title: Viracor SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-03
  device: MGH COVID-19 qPCR assay
  entity: Massachusetts General Hospital
  last_update: 2020-04-03
  links:
  - href: https://www.fda.gov/media/136700/download
    title: Mass-MGH-Letter
    type: letter of authorization
  - href: https://www.fda.gov/media/136699/download
    title: Massachusetts General Hospital - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-02
  device: SARS-Cov-2 Assay
  entity: Diagnostic Molecular Laboratory - Northwestern Medicine
  last_update: 2020-04-02
  links:
  - href: https://www.fda.gov/media/136658/download
    title: NWEST SARS LETTER
  - href: https://www.fda.gov/media/136669/download
    title: NWest-SARS-EUA-Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-02
  device: SARS-CoV-2 RT-PCR test
  entity: Infectious Disease Diagnostics Laboratory - Children's Hospital of Philadelphia
  last_update: 2020-04-02
  links:
  - href: https://www.fda.gov/media/136657/download
    title: CHOPS SARS LETTER
  - href: https://www.fda.gov/media/136656/download
    title: CHOPS SARS EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-03-31
  device: SARS-CoV-2 PCR test
  entity: "Yale New Haven Hospital,\n\t\t\tClinical Virology Laboratory"
  last_update: 2020-06-04
  links:
  - href: https://www.fda.gov/media/136601/download
    title: SARS-CoV-2 PCR test - Yale - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136602/download
    title: SARS-CoV-2 PCR test - Yale - Summary
    type: eua summary
  - href: https://www.fda.gov/media/138622/download
    title: Yale New Haven SARS CoV-2 Assay - Letter Granting EUA Amendment(s) (June
      4, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-10
  device: UNC Health SARS-CoV-2 real-time RT-PCR test
  entity: University of North Carolina Medical Center
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/136879/download
    title: UNC Health SARS-CoV-2 real-time RT-PCR test - Letter Granting Inclusion
      Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/136880/download
    title: UNC Health SARS-CoV-2 real-time RT-PCR test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-13
  device: SARS-CoV-2 Assay
  entity: Integrity Laboratories
  last_update: 2020-04-13
  links:
  - href: https://www.fda.gov/media/136941/download
    title: Integrity Laboratories SARS-CoV-2 Assay - Letter Granting Inclusion Under
      EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/136942/download
    title: Integrity Laboratories SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-13
  device: COVID-19 RT-PCR Test
  entity: Pathology/Laboratory Medicine Lab of Baptist Hospital Miami
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/136943/download
    title: Pathology/Laboratory Medicine Lab of Baptist Hospital Miami COVID-19 RT-PCR
      Test - Letter Granting Inclusion Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/136944/download
    title: Pathology/Laboratory Medicine Lab of Baptist Hospital Miami COVID-19 RT-PCR
      Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-14
  device: Childrens-Altona-SARS-CoV-2 Assay
  entity: Infectious Diseases Diagnostics Laboratory (IDDL), Boston Children's Hospital
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/136972/download
    title: Boston Altona Letter
    type: letter of authorization
  - href: https://www.fda.gov/media/136971/download
    title: Boston Altona EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-15
  device: CDI Enhanced COVID-19 Test
  entity: Hackensack University Medical Center (HUMC) Molecular Pathology Laboratory
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/137037/download
    title: Hackensack University Medical Center Letter
    type: letter of authorization
  - href: https://www.fda.gov/media/137036/download
    title: Hackensack University Medical Center  EUA
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-15
  device: CirrusDx SARS-CoV-2 Assay
  entity: CirrusDx Laboratories
  last_update: 2020-09-21
  links:
  - href: https://www.fda.gov/media/137035/download
    title: CirrusDx Laboratories Letter
    type: letter of authorization
  - href: https://www.fda.gov/media/137034/download
    title: 'CirrusDx Laboratories EUA '
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-14
  device: SARS-CoV-2 Test
  entity: Exact Sciences Laboratories
  last_update: 2020-04-14
  links:
  - href: https://www.fda.gov/media/137094/download
    title: Exact Sciences Laboratories SARS-CoV-2 Test - Letter Granting Inclusion
      Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/137095/download
    title: Exact Sciences Laboratories SARS-CoV-2 Test - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-20
  device: SARS-CoV-2 Molecular Detection Assay
  entity: Mayo Clinic Laboratories, Rochester, MN
  last_update: 2020-07-29
  links:
  - href: https://www.fda.gov/media/137162/download
    title: SARS-CoV-2 Molecular Detection Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137163/download
    title: SARS-CoV-2 Molecular Detection Assay - Summary
    type: eua summary
  - href: https://www.fda.gov/media/140636/download
    title: SARS-CoV-2 Molecular Detection Assay (Mayo Clinic) - Letter Granting EUA
      Amendment(s) (July 29, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-23
  device: COVID-19 Key
  entity: Southwest Regional PCR Laboratory LLC. dba MicroGen DX
  last_update: 2020-04-23
  links:
  - href: https://www.fda.gov/media/137369/download
    title: Southwest Regional PCR Laboratory LLC. dba MicroGen DX COVID-19 Key - Letter
      Granting Inclusion Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/137370/download
    title: Southwest Regional PCR Laboratory LLC. dba MicroGen DX COVID-19 Key - EUA
      Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-24
  device: UDX SARS-CoV-2 Molecular Assay
  entity: Ultimate Dx Laboratory
  last_update: 2020-04-24
  links:
  - href: https://www.fda.gov/media/137371/download
    title: UDX SARS-CoV-2 Molecular Assay - Letter Granting Inclusion Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/137372/download
    title: UDX SARS-CoV-2 Molecular Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-04-24
  device: SARS-CoV-2 Assay
  entity: AIT Laboratories
  last_update: 2020-04-24
  links:
  - href: https://www.fda.gov/media/137373/download
    title: AIT Laboratories SARS-CoV-2 Assay - Letter Granting Inclusion Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/137374/download
    title: AIT Laboratories SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-05-03
  device: UTHSC/UCH SARS-CoV-2-RT-PCR Assay
  entity: UTMG Pathology Laboratory
  last_update: 2020-07-22
  links:
  - href: https://www.fda.gov/media/137654/download
    title: EUA UTMG SARS Letter
    type: letter of authorization
  - href: https://www.fda.gov/media/137656/download
    title: EUA UTMG-SARS Summary
    type: eua summary
  - href: https://www.fda.gov/media/140376/download
    title: EUA UTMB SARS Amendment
    type: amendment
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-05-07
  device: Biocollections Worldwide SARS-Co-V-2 Assay
  entity: Biocollections Worldwide, Inc.
  last_update: 2020-05-07
  links:
  - href: https://www.fda.gov/media/137896/download
    title: Biocollections Worldwide SARS-Co-V-2 Assay - Letter Granting Inclusion
      Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/137897/download
    title: Biocollections Worldwide SARS-Co-V-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-05-12
  device: TRIPLEX CII-SARS-CoV-2 rRT-PCR TEST
  entity: Columbia University Laboratory of Personalized Genomic Medicine
  last_update: 2020-09-14
  links:
  - href: https://www.fda.gov/media/137982/download
    title: EUA Columbia University Laboratory of Personalized Genomic Medicine -  Letter
      of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137983/download
    title: EUA Columbia University Laboratory of Personalized Genomic Medicine - Summary
    type: eua summary
  - href: https://www.fda.gov/media/142161/download
    title: TRIPLEX CII-SARS-CoV-2 rRT-PCR TEST - Letter Granting EUA Revision(s) (September
      14, 2020)
    type: letter of authorization
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-05-13
  device: SARS-CoV-2 Real-Time RT-PCR-Test
  entity: One Health Laboratories, LLC
  last_update: 2020-05-13
  links:
  - href: https://www.fda.gov/media/138062/download
    title: One Health Laboratories LLC.- Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138063/download
    title: One Health Laboratories LLC-EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-05-13
  device: SARS-CoV-2-Assay
  entity: Cedars-Sinai Medical Center, Department of Pathology and Laboratory Medicine
  last_update: 2020-05-13
  links:
  - href: https://www.fda.gov/media/138064/download
    title: Cedars-Sinai Medical Center - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138065/download
    title: Cedars-Sinai Medical Center - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-06-01
  device: Aspirus SARS-CoV rRT Assay
  entity: Aspirus Reference Laboratory
  last_update: 2020-06-01
  links:
  - href: https://www.fda.gov/media/138527/download
    title: Aspirus SARS Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138526/download
    title: Asprius SARS EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-06-04
  device: NEcov19 RT-PCR Assay
  entity: Nebraska Medicine Clinical Laboratory
  last_update: 2020-06-04
  links:
  - href: https://www.fda.gov/media/138624/download
    title: Nebraska Medicine Clinical Laboratory NEcov19 RT-PCR Assay - Letter Granting
      Inclusion Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/138625/download
    title: Nebraska Medicine Clinical Laboratory NEcov19 RT-PCR Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-06-01
  device: CSI SARS-CoV-2 RT PCR Test
  entity: CSI Laboratories
  last_update: 2020-06-01
  links:
  - href: https://www.fda.gov/media/138529/download
    title: CSI SARS Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138528/download
    title: CSI SARS EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-05-22
  device: Express Gene 2019-nCoV RT-PCR Diagnostic Panel
  entity: Express Gene LLC (dba Molecular Diagnostics Laboratory)
  last_update: 2020-05-22
  links:
  - href: https://www.fda.gov/media/138329/download
    title: Express Gene 2019-nCoV RT-PCR Diagnostic Panel - Letter Granting Inclusion
      Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/138330/download
    title: Express Gene 2019-nCoV RT-PCR Diagnostic Panel - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-05-22
  device: Avera Institute for Human Genetics SARS-CoV-2 Assay
  entity: Avera Institute for Human Genetics
  last_update: 2020-05-22
  links:
  - href: https://www.fda.gov/media/138331/download
    title: Avera Institute for Human Genetics SARS-CoV-2 Assay - Letter Granting Inclusion
      Under EUA
    type: letter of authorization
  - href: https://www.fda.gov/media/138332/download
    title: Avera Institute for Human Genetics SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-06-10
  device: Warrior Diagnostics SARS-CoV-2 Assay
  entity: Warrior Diagnostics, Inc.
  last_update: 2020-06-10
  links:
  - href: https://www.fda.gov/media/138791/download
    title: Warrior Diagnostics SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138790/download
    title: Warrior Diagnostics SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- approval_date: 2020-06-12
  device: Cormeum SARS-CoV-2 Assay
  entity: Cormeum Laboratory Services
  last_update: 2020-06-12
  links:
  - href: https://www.fda.gov/media/138933/download
    title: Cormeum SARS-CoV-2 Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138934/download
    title: Cormeum SARS-CoV-2 Assay - EUA Summary
    type: eua summary
  method: molecular
  settings:
  - H
  type: diagnostic
- amendments:
  - 2020-06-09
  approval_date: 2020-05-08
  device: Sofia SARS Antigen FIA
  entity: Quidel Corporation
  last_update: 2020-07-17
  links:
  - href: https://www.fda.gov/media/137886/download
    title: Sofia 2 SARS Antigen FIA - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137884/download
    title: Sofia 2 SARS Antigen FIA - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137887/download
    title: Sofia 2 SARS Antigen FIA - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137885/download
    title: Sofia 2 SARS Antigen FIA - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/138789/download
    title: Sofia 2 SARS Antigen FIA - Amendment June 9, 2020
    type: amendment
  - href: https://www.fda.gov/media/140299/download
    title: Sofia SARS Antigen FIA - Letter Granting EUA Amendment(s) (July 17, 2020)
    type: letter of authorization
  method: antigen
  settings:
  - H
  - M
  - W
  technology: Lateral Flow, Fluorescence, Instrument Read
  type: diagnostic
- amendments:
  - 2020-07-23
  approval_date: 2020-07-02
  device: BD Veritor System for Rapid Detection of SARS-CoV-2
  entity: Becton, Dickinson and Company (BD)
  last_update: 2020-07-23
  links:
  - href: https://www.fda.gov/media/139752/download
    title: BD Veritor System for Rapid Detection of SARS-CoV-2 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139753/download
    title: BD Veritor System for Rapid Detection of SARS-CoV-2 - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139754/download
    title: BD Veritor System for Rapid Detection of SARS-CoV-2 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/139755/download
    title: BD Veritor System for Rapid Detection of SARS-CoV-2 - IFU
  - href: https://www.fda.gov/media/140429/download
    title: BD Veritor System for Rapid Detection of SARS-CoV-2 - Amendment July 23,
      2020
    type: amendment
  method: antigen
  settings:
  - H
  - M
  - W
  technology: Chromatographic Digital Immunoassay, Instrument Read
  type: diagnostic
- approval_date: 2020-08-18
  device: LumiraDx SARS-CoV-2 Ag Test
  entity: LumiraDx UK Ltd.
  last_update: 2020-08-18
  links:
  - href: https://www.fda.gov/media/141301/download
    title: LumiraDx SARS-CoV-2 Ag Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141302/download
    title: LumiraDx SARS-CoV-2 Ag Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141303/download
    title: LumiraDx SARS-CoV-2 Ag Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141304/download
    title: LumiraDx SARS-CoV-2 Ag Test - Instructions for Use
    type: instructions for use
  method: antigen
  settings:
  - H
  - M
  - W
  technology: Microfluidic Immunofluorescence Assay, Instrument Read
  type: diagnostic
- approval_date: 2020-08-26
  device: BinaxNOW COVID-19 Ag Card
  entity: Abbott Diagnostics Scarborough, Inc.
  last_update: 2020-08-26
  links:
  - href: https://www.fda.gov/media/141567/download
    title: BinaxNOW COVID-19 Ag Card - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141568/download
    title: BinaxNOW COVID-19 Ag Card - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141569/download
    title: BinaxNOW COVID-19 Ag Card - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/141570/download
    title: BinaxNOW COVID-19 Ag Card - IFU
  method: antigen
  settings:
  - H
  - M
  - W
  technology: Lateral Flow, Visual Read
  type: diagnostic
- amendments:
  - 2020-02-01
  approval_date: 2020-04-26
  device: SARS-CoV-2 IgG assay
  entity: Abbott Laboratories Inc.
  last_update: 2020-09-18
  links:
  - href: https://www.fda.gov/media/137384/download
    title: EUA Abbott Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137381/download
    title: Abbott Lab Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137382/download
    title: Abbott Lab Fact Sheet for Recipients
  - href: https://www.fda.gov/media/137383/download
    title: Abbott Lab EUA IFU
  - href: https://www.fda.gov/media/137910/download
    title: SARS-CoV-2 IgG assay - Alinity IFU
  - href: https://www.fda.gov/media/137911/download
    title: SARS-CoV-2 IgG assay - Amendment
    type: amendment
  - href: https://www.fda.gov/media/139406/download
    title: Abbott Laboratories Inc. SARS-CoV-2 IgG assay - Letter Granting EUA Amendment(s)
      (June 22, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/142306/download
    title: Abbot SARS-CoV-2 IgG assay - Letter Granting EUA Revision(s) (September
      18, 2020)
    type: letter of authorization
  method: serological
  settings:
  - H
  - M
  technology: IgG, CMIA
  type: diagnostic
- approval_date: 2020-04-01
  device: qSARS-CoV-2 IgG/IgM Rapid Test
  entity: Cellex Inc.
  last_update: 2020-06-12
  links:
  - href: https://www.fda.gov/media/136622/download
    title: qSARS-CoV-2 IgG/IgM Rapid Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/136623/download
    title: qSARS-CoV-2 IgG/IgM Rapid Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/136624/download
    title: qSARS-CoV-2 IgG/IgM Rapid Test - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/136625/download
    title: qSARS-CoV-2 IgG/IgM Rapid Test - IFU
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- amendments:
  - 2020-02-01
  approval_date: 2020-04-14
  device: VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack
  entity: Ortho Clinical Diagnostics, Inc.
  last_update: 2020-04-24
  links:
  - href: https://www.fda.gov/media/136966/download
    title: Ortho Vitro Letters
    type: letter of authorization
  - href: https://www.fda.gov/media/136970/download
    title: Ortho Vitros HCP
  - href: https://www.fda.gov/media/136969/download
    title: Ortho Vitros - Recipients
  - href: https://www.fda.gov/media/136967/download
    title: Ortho Vitros IFU
  - href: https://www.fda.gov/media/137920/download
    title: VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack - Amendment
    type: amendment
  method: serological
  settings:
  - H
  - M
  technology: Total Antibody, CLIA
  type: diagnostic
- approval_date: 2020-04-15
  device: COVID-19 ELISA IgG Antibody Test
  entity: Mount Sinai Laboratory
  last_update: 2020-04-15
  links:
  - href: https://www.fda.gov/media/137032/download
    title: Mount Sinai Laboratory Letter
    type: letter of authorization
  - href: https://www.fda.gov/media/137030/download
    title: Mount Sinai Laboratory HCP
  - href: https://www.fda.gov/media/137033/download
    title: Mount Sinai Laboratory Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/137029/download
    title: Mount Sinai Laboratory EUA
  method: serological
  settings:
  - H
  technology: IgG, ELISA
  type: diagnostic
- approval_date: 2020-04-24
  device: LIAISON SARS-CoV-2 S1/S2 IgG
  entity: DiaSorin Inc.
  last_update: 2020-07-22
  links:
  - href: https://www.fda.gov/media/137356/download
    title: DiaSorin Inc. LIAISON SARS-CoV-2 S1/S2 IgG - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137357/download
    title: DiaSorin Inc. LIAISON SARS-CoV-2 S1/S2 IgG - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137358/download
    title: DiaSorin Inc. LIAISON SARS-CoV-2 S1/S2 IgG - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/137359/download
    title: DiaSorin Inc. LIAISON SARS-CoV-2 S1/S2 IgG - IFU
  - href: https://www.fda.gov/media/140377/download
    title: LIAISON SARS-CoV-2 S1/S2 IgG - Letter Granting EUA Amendment(s) (July 22,
      2020)
    type: letter of authorization
  method: serological
  settings:
  - H
  - M
  technology: IgG, CLIA
  type: diagnostic
- approval_date: 2020-04-24
  device: VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack
  entity: Ortho-Clinical Diagnostics, Inc.
  last_update: 2020-04-24
  links:
  - href: https://www.fda.gov/media/137360/download
    title: VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack - Letter
      of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137361/download
    title: VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack - Fact
      Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137362/download
    title: VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack - Fact
      Sheet for Recipients
  - href: https://www.fda.gov/media/137363/download
    title: VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack - IFU
  method: serological
  settings:
  - H
  - M
  technology: IgG, CLIA
  type: diagnostic
- amendments:
  - 2020-07-21
  approval_date: 2020-04-29
  device: Platelia SARS-CoV-2 Total Ab assay
  entity: Bio-Rad Laboratories, Inc.
  last_update: 2020-07-21
  links:
  - href: https://www.fda.gov/media/137494/download
    title: Platelia SARS-CoV-2 Total Ab assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137492/download
    title: Platelia SARS-CoV-2 Total Ab assay - Information for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137495/download
    title: Platelia SARS-CoV-2 Total Ab assay - Information for Recipients
  - href: https://www.fda.gov/media/137493/download
    title: Platelia SARS-CoV-2 Total Ab assay - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/140335/download
    title: Platelia SARS-CoV-2 Total Ab assay - Amendment July 21, 2020
    type: amendment
  method: serological
  settings:
  - H
  technology: Total Antibody, ELISA
  type: diagnostic
- approval_date: 2020-04-30
  device: New York SARS-CoV Microsphere Immunoassay for Antibody Detection
  entity: Wadsworth Center, New York State Department of Health
  last_update: 2020-04-30
  links:
  - href: https://www.fda.gov/media/137540/download
    title: New York SARS-CoV Microsphere Immunoassay for Antibody Detection - Letter
      of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137542/download
    title: New York SARS-CoV Microsphere Immunoassay for Antibody Detection - Fact
      Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137543/download
    title: New York SARS-CoV Microsphere Immunoassay for Antibody Detection - Fact
      Sheet for Recipients
  - href: https://www.fda.gov/media/137541/download
    title: New York SARS-CoV Microsphere Immunoassay for Antibody Detection - EUA
      Summary
    type: eua summary
  method: serological
  settings:
  - H
  technology: Total Antibody, FMIA
  type: diagnostic
- approval_date: 2020-05-02
  device: Elecsys Anti-SARS-CoV-2
  entity: Roche Diagnostics
  last_update: 2020-07-21
  links:
  - href: https://www.fda.gov/media/137602/download
    title: Roche Diagnostics Elecsys Anti-SARS-CoV-2 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137603/download
    title: Roche Diagnostics Elecsys Anti-SARS-CoV-2 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137604/download
    title: Roche Diagnostics Elecsys Anti-SARS-CoV-2 - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/137605/download
    title: Roche Diagnostics Elecsys Anti-SARS-CoV-2 - IFU
  - href: https://www.fda.gov/media/138667/download
    title: Roche Diagnostics Elecsys Anti-SARS-CoV-2 - Letter Granting EUA Amendment(s)
      (June 4, 2020)
    type: letter of authorization
  - href: https://www.fda.gov/media/140538/download
    title: Roche Diagnostics Elecsys Anti-SARS-CoV-2 - Letter Granting EUA Amendment(s)
      (July 21, 2020)
    type: letter of authorization
  method: serological
  settings:
  - H
  - M
  technology: Total Antibody, ECLIA
  type: diagnostic
- approval_date: 2020-05-04
  device: Anti-SARS-CoV-2 ELISA (IgG)
  entity: EUROIMMUN US Inc.
  last_update: 2020-05-04
  links:
  - href: https://www.fda.gov/media/137606/download
    title: EUROIMMUN US Inc. Anti-SARS-CoV-2 ELISA (IgG) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/137607/download
    title: EUROIMMUN US Inc. Anti-SARS-CoV-2 ELISA (IgG) - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/137608/download
    title: EUROIMMUN US Inc. Anti-SARS-CoV-2 ELISA (IgG) - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/137609/download
    title: EUROIMMUN US Inc. Anti-SARS-CoV-2 ELISA (IgG) - IFU
  method: serological
  settings:
  - H
  technology: IgG, ELISA
  type: diagnostic
- approval_date: 2020-05-29
  device: COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma)
  entity: Healgen Scientific LLC
  last_update: 2020-05-29
  links:
  - href: https://www.fda.gov/media/138435/download
    title: Healgen Scientific LLC Diagnostic COVID-19 IgG/IgM Rapid Test Cassette
      (WB/S/P) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138436/download
    title: Healgen Scientific LLC Diagnostic COVID-19 IgG/IgM Rapid Test Cassette
      (WB/S/P) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138437/download
    title: Healgen Scientific LLC Diagnostic COVID-19 IgG/IgM Rapid Test Cassette
      (WB/S/P) - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/138438/download
    title: Healgen Scientific LLC Diagnostic COVID-19 IgG/IgM Rapid Test Cassette
      (WB/S/P) - IFU
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG Lateral Flow
  type: diagnostic
- approval_date: 2020-05-29
  device: Atellica IM SARS-CoV-2 Total (COV2T)
  entity: Siemens Healthcare Diagnostics Inc.
  last_update: 2020-05-29
  links:
  - href: https://www.fda.gov/media/138439/download
    title: Siemens Healthcare Diagnostics Inc. Atellica IM SARS-CoV-2 Total (COV2T)
      - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138440/download
    title: Siemens Healthcare Diagnostics Inc. Atellica IM SARS-CoV-2 Total (COV2T)
      - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138441/download
    title: Siemens Healthcare Diagnostics Inc. Atellica IM SARS-CoV-2 Total (COV2T)
      - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/138442/download
    title: Siemens Healthcare Diagnostics Inc. Atellica IM SARS-CoV-2 Total (COV2T)
      - IFU
  method: serological
  settings:
  - H
  - M
  technology: Total Antibody, CLIA
  type: diagnostic
- approval_date: 2020-05-29
  device: ADVIA Centaur SARS-CoV-2 Total (COV2T)
  entity: Siemens Healthcare Diagnostics Inc.
  last_update: 2020-05-29
  links:
  - href: https://www.fda.gov/media/138443/download
    title: Siemens Healthcare Diagnostics Inc. ADVIA Centaur SARS-CoV-2 Total (COV2T)
      - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138444/download
    title: Siemens Healthcare Diagnostics Inc. ADVIA Centaur SARS-CoV-2 Total (COV2T)
      - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138445/download
    title: Siemens Healthcare Diagnostics Inc. ADVIA Centaur SARS-CoV-2 Total (COV2T)
      - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/138446/download
    title: Siemens Healthcare Diagnostics Inc. ADVIA Centaur SARS-CoV-2 Total (COV2T)
      - IFU
  method: serological
  settings:
  - H
  - M
  technology: Total Antibody, CLIA
  type: diagnostic
- approval_date: 2020-06-04
  device: Vibrant COVID-19 Ab Assay
  entity: Vibrant America Clinical Labs
  last_update: 2020-06-04
  links:
  - href: https://www.fda.gov/media/138626/download
    title: Vibrant COVID-19 Ab Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138627/download
    title: Vibrant COVID-19 Ab Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138628/download
    title: Vibrant COVID-19 Ab Assay - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/138629/download
    title: Vibrant COVID-19 Ab Assay - EUA Summary
    type: eua summary
  method: serological
  settings:
  - H
  technology: IgM and IgG, CLIA
  type: diagnostic
- amendments:
  - 2020-07-23
  approval_date: 2020-06-04
  device: RightSign COVID-19 IgG/IgM Rapid Test Cassette
  entity: Hangzhou Biotest Biotech Co., Ltd.
  last_update: 2020-08-31
  links:
  - href: https://www.fda.gov/media/138657/download
    title: RightSign COVID-19 IgG/IgM Rapid Test Cassette - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138658/download
    title: RightSign COVID-19 IgG/IgM Rapid Test Cassette - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138659/download
    title: RightSign COVID-19 IgG/IgM Rapid Test Cassette - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/138660/download
    title: RightSign COVID-19 IgG/IgM Rapid Test Cassette - IFU
  - href: https://www.fda.gov/media/140428/download
    title: RightSign COVID-19 IgG/IgM Rapid Test Cassette - Amendment July 23, 2020
    type: amendment
  - href: https://www.fda.gov/media/141751/download
    title: RightSign COVID-19 IgG/IgM Rapid Test Cassette - Letter Granting EUA Revision(s)
      (August 31, 2020)
    type: letter of authorization
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG Lateral Flow
  type: diagnostic
- approval_date: 2020-06-08
  device: Dimension Vista SARS-CoV-2 Total antibody assay (COV2T)
  entity: Siemens Healthcare Diagnostics Inc.
  last_update: 2020-08-07
  links:
  - href: https://www.fda.gov/media/138750/download
    title: Dimension Vista SARS-CoV-2 Total antibody assay (COV2T) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138751/download
    title: Dimension Vista SARS-CoV-2 Total antibody assay (COV2T) - Fact Sheet for
      Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138752/download
    title: Dimension Vista SARS-CoV-2 Total antibody assay (COV2T) - Fact Sheet for
      Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138753/download
    title: Dimension Vista SARS-CoV-2 Total antibody assay (COV2T) - Instructions
      for Use
    type: instructions for use
  - href: https://www.fda.gov/media/140982/download
    title: Dimension Vista SARS-CoV-2 Total antibody assay (COV2T) - Letter Granting
      EUA Amendment(s) (August 7, 2020)
    type: letter of authorization
  method: serological
  settings:
  - H
  - M
  technology: Total Antibody, CLIA
  type: diagnostic
- approval_date: 2020-06-08
  device: Dimension EXL SARS-CoV-2 Total antibody assay (CV2T)
  entity: Siemens Healthcare Diagnostics Inc.
  last_update: 2020-08-07
  links:
  - href: https://www.fda.gov/media/138754/download
    title: Dimension EXL SARS-CoV-2 Total antibody assay (CV2T) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138755/download
    title: Dimension EXL SARS-CoV-2 Total antibody assay (CV2T) - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138756/download
    title: Dimension EXL SARS-CoV-2 Total antibody assay (CV2T) - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138757/download
    title: Dimension EXL SARS-CoV-2 Total antibody assay (CV2T) - Instructions for
      Use
    type: instructions for use
  - href: https://www.fda.gov/media/140981/download
    title: Dimension EXL SARS-CoV-2 Total antibody assay (CV2T) - Letter Granting
      EUA Amendment(s) (August 7, 2020)
    type: letter of authorization
  method: serological
  settings:
  - H
  - M
  technology: Total Antibody, CLIA
  type: diagnostic
- approval_date: 2020-06-10
  device: SCoV-2 Detect IgG ELISA
  entity: InBios International, Inc.
  last_update: 2020-06-10
  links:
  - href: https://www.fda.gov/media/138807/download
    title: SCoV-2 Detect IgG ELISA - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138808/download
    title: SCoV-2 Detect IgG ELISA - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/138809/download
    title: SCoV-2 Detect IgG ELISA - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/138810/download
    title: SCoV-2 Detect IgG ELISA - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  technology: IgG, ELISA
  type: diagnostic
- approval_date: 2020-06-15
  device: SARS-CoV-2 RBD IgG test
  entity: Emory Medical Laboratories
  last_update: 2020-06-15
  links:
  - href: https://www.fda.gov/media/139050/download
    title: SARS-CoV-2 RBD IgG test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139051/download
    title: SARS-CoV-2 RBD IgG test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139052/download
    title: SARS-CoV-2 RBD IgG test - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/139053/download
    title: SARS-CoV-2 RBD IgG test - EUA Summary
    type: eua summary
  method: serological
  settings:
  - H
  technology: IgG, ELISA
  type: diagnostic
- approval_date: 2020-06-18
  device: Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit
  entity: Biohit Healthcare (Hefei) Co. Ltd.
  last_update: 2020-08-03
  links:
  - href: https://www.fda.gov/media/139280/download
    title: Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139281/download
    title: Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139282/download
    title: Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/139283/download
    title: Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit - Instructions for Use
    type: instructions for use
  - href: https://www.fda.gov/media/140782/download
    title: Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit - Letter Granting EUA Amendment(s)
      (August 3, 2020)
    type: letter of authorization
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG Lateral Flow
  type: diagnostic
- approval_date: 2020-06-19
  device: LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal
    Gold)
  entity: Hangzhou Laihe Biotech Co., Ltd.
  last_update: 2020-08-12
  links:
  - href: https://www.fda.gov/media/139407/download
    title: LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal
      Gold) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139409/download
    title: LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal
      Gold) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139408/download
    title: LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal
      Gold) - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/139410/download
    title: LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal
      Gold) - IFU
  - href: https://www.fda.gov/media/141150/download
    title: LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal
      Gold) - Letter Granting EUA Revision(s) (August 12, 2020)
    type: letter of authorization
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG Lateral Flow
  type: diagnostic
- approval_date: 2020-06-23
  device: Babson Diagnostics aC19G1
  entity: Babson Diagnostics, Inc.
  last_update: 2020-06-23
  links:
  - href: https://www.fda.gov/media/139450/download
    title: Babson Diagnostics aC19G1 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139447/download
    title: Babson Diagnostics aC19G1 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139448/download
    title: Babson Diagnostics aC19G1 - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/139446/download
    title: Babson Diagnostics aC19G1 - EUA Summary
    type: eua summary
  method: serological
  settings:
  - H
  technology: IgG, CLIA
  type: diagnostic
- approval_date: 2020-06-26
  device: Access SARS-CoV-2 IgG
  entity: Beckman Coulter, Inc.
  last_update: 2020-06-26
  links:
  - href: https://www.fda.gov/media/139624/download
    title: Beckman Coulter, Inc. Access SARS-CoV-2 IgG - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139625/download
    title: Beckman Coulter, Inc. Access SARS-CoV-2 IgG - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139626/download
    title: Beckman Coulter, Inc. Access SARS-CoV-2 IgG - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/139627/download
    title: Beckman Coulter, Inc. Access SARS-CoV-2 IgG - IFU
  method: serological
  settings:
  - H
  - M
  technology: IgG, CLIA
  type: diagnostic
- approval_date: 2020-06-30
  device: SCoV-2 Detect IgM ELISA
  entity: InBios International, Inc.
  last_update: 2020-06-30
  links:
  - href: https://www.fda.gov/media/139726/download
    title: SCoV-2 Detect IgM ELISA - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139727/download
    title: SCoV-2 Detect IgM ELISA - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139729/download
    title: SCoV-2 Detect IgM ELISA - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/139730/download
    title: SCoV-2 Detect IgM ELISA - Information for Use
  method: serological
  settings:
  - H
  technology: IgM, ELISA
  type: diagnostic
- approval_date: 2020-07-06
  device: Assure COVID-19 IgG/IgM Rapid Test Device
  entity: Assure Tech. (Hangzhou Co., Ltd)
  last_update: 2020-09-23
  links:
  - href: https://www.fda.gov/media/139789/download
    title: Assure COVID-19 IgG/IgM Rapid Test Device - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139790/download
    title: Assure COVID-19 IgG/IgM Rapid Test Device - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139791/download
    title: Assure COVID-19 IgG/IgM Rapid Test Device - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/139792/download
    title: Assure COVID-19 IgG/IgM Rapid Test Device - IFU
  method: serological
  settings:
  - H
  - M
  - W
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-07-08
  device: Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit
  entity: Diazyme Laboratories, Inc.
  last_update: 2020-07-08
  links:
  - href: https://www.fda.gov/media/139866/download
    title: Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/139863/download
    title: Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/139867/download
    title: Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/139865/download
    title: Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgG, CLIA
  type: diagnostic
- approval_date: 2020-07-10
  device: WANTAI SARS-CoV-2 Ab Rapid Test
  entity: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  last_update: 2020-07-10
  links:
  - href: https://www.fda.gov/media/140035/download
    title: WANTAI SARS-CoV-2 Ab Rapid Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140028/download
    title: WANTAI SARS-CoV-2 Ab Rapid Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140037/download
    title: WANTAI SARS-CoV-2 Ab Rapid Test - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140030/download
    title: WANTAI SARS-CoV-2 Ab Rapid Test - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: Total Antibody, Lateral Flow
  type: diagnostic
- approval_date: 2020-07-13
  device: Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette
  entity: Salofa Oy
  last_update: 2020-07-13
  links:
  - href: https://www.fda.gov/media/140079/download
    title: Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette - Letter
      of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140080/download
    title: Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette - Fact Sheet
      for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140081/download
    title: Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette - Fact Sheet
      for Recipients
  - href: https://www.fda.gov/media/140082/download
    title: Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette - Information
      for Use
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-07-16
  device: xMAP SARS-CoV-2 Multi-Antigen IgG Assay
  entity: Luminex Corporation
  last_update: 2020-07-16
  links:
  - href: https://www.fda.gov/media/140257/download
    title: xMAP SARS-CoV-2 Multi-Antigen IgG Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140255/download
    title: xMAP SARS-CoV-2 Multi-Antigen IgG Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140258/download
    title: xMAP SARS-CoV-2 Multi-Antigen IgG Assay - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140256/download
    title: xMAP SARS-CoV-2 Multi-Antigen IgG Assay - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  technology: IgG, FMIA
  type: diagnostic
- approval_date: 2020-07-17
  device: Rapid COVID-19 IgM/IgG Combo Test Kit
  entity: Megna Health, Inc.
  last_update: 2020-07-17
  links:
  - href: https://www.fda.gov/media/140294/download
    title: Rapid COVID-19 IgM/IgG Combo Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140295/download
    title: Rapid COVID-19 IgM/IgG Combo Test Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140296/download
    title: Rapid COVID-19 IgM/IgG Combo Test Kit - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140297/download
    title: Rapid COVID-19 IgM/IgG Combo Test Kit - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-07-24
  device: BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test
  entity: Xiamen Biotime Biotechnology Co., Ltd.
  last_update: 2020-07-24
  links:
  - href: https://www.fda.gov/media/140440/download
    title: BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140441/download
    title: BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140442/download
    title: BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140443/download
    title: BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-07-24
  device: CareStart COVID-19 IgM/IgG
  entity: Access Bio, Inc.
  last_update: 2020-07-24
  links:
  - href: https://www.fda.gov/media/140444/download
    title: CareStart COVID-19 IgM/IgG - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140445/download
    title: CareStart COVID-19 IgM/IgG - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140446/download
    title: CareStart COVID-19 IgM/IgG - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140447/download
    title: CareStart COVID-19 IgM/IgG - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-07-31
  device: Atellica IM SARS-CoV-2 IgG (COV2G)
  entity: Siemens Healthcare Diagnostics Inc.
  last_update: 2020-07-31
  links:
  - href: https://www.fda.gov/media/140700/download
    title: Atellica IM SARS-CoV-2 IgG (COV2G) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140698/download
    title: Atellica IM SARS-CoV-2 IgG (COV2G) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140701/download
    title: Atellica IM SARS-CoV-2 IgG (COV2G) - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140699/download
    title: Atellica IM SARS-CoV-2 IgG (COV2G) - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgG, Semi-quantitative
  type: diagnostic
- approval_date: 2020-07-31
  device: ADVIA Centaur SARS-CoV-2 IgG (COV2G)
  entity: Siemens Healthcare Diagnostics Inc.
  last_update: 2020-07-31
  links:
  - href: https://www.fda.gov/media/140703/download
    title: ADVIA Centaur SARS-CoV-2 IgG (COV2G) - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140702/download
    title: ADVIA Centaur SARS-CoV-2 IgG (COV2G) - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140705/download
    title: ADVIA Centaur SARS-CoV-2 IgG (COV2G) - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140704/download
    title: ADVIA Centaur SARS-CoV-2 IgG (COV2G) - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgG, Semi-quantitative
  type: diagnostic
- approval_date: 2020-08-05
  device: WANTAI SARS-CoV-2 Ab ELISA
  entity: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  last_update: 2020-08-05
  links:
  - href: https://www.fda.gov/media/140926/download
    title: WANTAI SARS-CoV-2 Ab ELISA - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140927/download
    title: WANTAI SARS-CoV-2 Ab ELISA - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140928/download
    title: WANTAI SARS-CoV-2 Ab ELISA - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140929/download
    title: WANTAI SARS-CoV-2 Ab ELISA - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  technology: Total Antibody, ELISA
  type: diagnostic
- approval_date: 2020-08-06
  device: VIDAS SARS-CoV-2 IgM
  entity: "bioM\xE9rieux SA"
  last_update: 2020-08-06
  links:
  - href: https://www.fda.gov/media/140930/download
    title: VIDAS SARS-CoV-2 IgM - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140931/download
    title: VIDAS SARS-CoV-2 IgM - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140932/download
    title: VIDAS SARS-CoV-2 IgM - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140933/download
    title: VIDAS SARS-CoV-2 IgM - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM, ELFA
  type: diagnostic
- approval_date: 2020-08-06
  device: VIDAS SARS-CoV-2 IgG
  entity: "bioM\xE9rieux SA"
  last_update: 2020-08-06
  links:
  - href: https://www.fda.gov/media/140934/download
    title: VIDAS SARS-CoV-2 IgG - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/140935/download
    title: VIDAS SARS-CoV-2 IgG - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/140936/download
    title: VIDAS SARS-CoV-2 IgG - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/140937/download
    title: VIDAS SARS-CoV-2 IgG - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgG, ELFA
  type: diagnostic
- approval_date: 2020-08-17
  device: BioCheck SARS-CoV-2 IgG and IgM Combo Test
  entity: BioCheck, Inc.
  last_update: 2020-08-17
  links:
  - href: https://www.fda.gov/media/141247/download
    title: BioCheck SARS-CoV-2 IgG and IgM Combo Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141248/download
    title: BioCheck SARS-CoV-2 IgG and IgM Combo Test - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141249/download
    title: BioCheck SARS-CoV-2 IgG and IgM Combo Test - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/141251/download
    title: BioCheck SARS-CoV-2 IgG and IgM Combo Test - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, CLIA
  type: diagnostic
- approval_date: 2020-08-17
  device: Diazyme DZ-Lite SARS-CoV-2 IgM CLIA Kit
  entity: Diazyme Laboratories, Inc.
  last_update: 2020-08-17
  links:
  - href: https://www.fda.gov/media/141252/download
    title: Diazyme DZ-Lite SARS-CoV-2 IgM CLIA Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141253/download
    title: Diazyme DZ-Lite SARS-CoV-2 IgM CLIA Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141254/download
    title: Diazyme DZ-Lite SARS-CoV-2 IgM CLIA Kit - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/141255/download
    title: Diazyme DZ-Lite SARS-CoV-2 IgM CLIA Kit - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM, CLIA
  type: diagnostic
- approval_date: 2020-08-25
  device: Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test - Letter
    of Authorization
  entity: Biocan Diagnostics Inc.
  last_update: 2020-08-25
  links:
  - href: https://www.fda.gov/media/141547/download
    title: Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test - Letter
      of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141548/download
    title: Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test - Fact
      Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141549/download
    title: Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test - Fact
      Sheet for Recipients
  - href: https://www.fda.gov/media/141550/download
    title: Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test - IFU
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-08-31
  device: TBG SARS-CoV-2 IgG / IgM Rapid Test Kit
  entity: TBG Biotechnology Corp.
  last_update: 2020-08-31
  links:
  - href: https://www.fda.gov/media/141770/download
    title: TBG SARS-CoV-2 IgG / IgM Rapid Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141771/download
    title: TBG SARS-CoV-2 IgG / IgM Rapid Test Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141772/download
    title: TBG SARS-CoV-2 IgG / IgM Rapid Test Kit - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/141773/download
    title: TBG SARS-CoV-2 IgG / IgM Rapid Test Kit - IFU
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-08-31
  device: COVID-19 ELISA pan-Ig Antibody Test
  entity: University of Arizona Genetics Core for Clinical Services
  last_update: 2020-08-31
  links:
  - href: https://www.fda.gov/media/141774/download
    title: Arizona COVID-19 ELISA pan-Ig Antibody Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141775/download
    title: Arizona COVID-19 ELISA pan-Ig Antibody Test - Fact Sheet for Healthcare
      Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141776/download
    title: Arizona COVID-19 ELISA pan-Ig Antibody Test - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/141777/download
    title: Arizona COVID-19 ELISA pan-Ig Antibody Test - EUA Summary
    type: eua summary
  method: serological
  settings:
  - H
  technology: Total Antibody, ELISA
  type: diagnostic
- approval_date: 2020-09-03
  device: SGTi-flex COVID-19 IgG
  entity: Sugentech, Inc.
  last_update: 2020-09-03
  links:
  - href: https://www.fda.gov/media/141888/download
    title: SGTi-flex COVID-19 IgG - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141889/download
    title: SGTi-flex COVID-19 IgG - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/141890/download
    title: SGTi-flex COVID-19 IgG - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/141891/download
    title: SGTi-flex COVID-19 IgG - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-09-09
  device: BioCheck SARS-CoV-2 IgM Antibody Test Kit
  entity: BioCheck, Inc.
  last_update: 2020-09-09
  links:
  - href: https://www.fda.gov/media/141998/download
    title: BioCheck SARS-CoV-2 IgM Antibody Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/141999/download
    title: BioCheck SARS-CoV-2 IgM Antibody Test Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142000/download
    title: BioCheck SARS-CoV-2 IgM Antibody Test Kit - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/142002/download
    title: BioCheck SARS-CoV-2 IgM Antibody Test Kit - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM, CLIA
  type: diagnostic
- approval_date: 2020-09-09
  device: BioCheck SARS-CoV-2 IgG Antibody Test Kit
  entity: BioCheck, Inc.
  last_update: 2020-09-09
  links:
  - href: https://www.fda.gov/media/142003/download
    title: BioCheck SARS-CoV-2 IgG Antibody Test Kit - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142004/download
    title: BioCheck SARS-CoV-2 IgG Antibody Test Kit - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142005/download
    title: BioCheck SARS-CoV-2 IgG Antibody Test Kit - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/142006/download
    title: BioCheck SARS-CoV-2 IgG Antibody Test Kit - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgG, CLIA
  type: diagnostic
- approval_date: 2020-09-14
  device: MAGLUMI 2019-nCoV IgM/IgG
  entity: Shenzhen New Industries Biomedical Engineering Co., Ltd.
  last_update: 2020-09-14
  links:
  - href: https://www.fda.gov/media/142230/download
    title: MAGLUMI 2019-nCoV IgM/IgG - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142231/download
    title: MAGLUMI 2019-nCoV IgM/IgG - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142232/download
    title: MAGLUMI 2019-nCoV IgM/IgG - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/142233/download
    title: MAGLUMI 2019-nCoV IgM/IgG - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, CLIA
  type: diagnostic
- approval_date: 2020-09-23
  device: Orawell IgM/IgG Rapid Test
  entity: Jiangsu Well Biotech Co., Ltd.
  last_update: 2020-09-23
  links:
  - href: https://www.fda.gov/media/142423/download
    title: Orawell IgM/IgG Rapid Test - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142421/download
    title: Orawell IgM/IgG Rapid Test - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142424/download
    title: Orawell IgM/IgG Rapid Test - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/142422/download
    title: Orawell IgM/IgG Rapid Test - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-09-25
  device: MosaiQ COVID-19 Antibody Magazine
  entity: Quotient Suisse SA
  last_update: 2020-09-25
  links:
  - href: https://www.fda.gov/media/142483/download
    title: MosaiQ COVID-19 Antibody Magazine - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142484/download
    title: MosaiQ COVID-19 Antibody Magazine - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142485/download
    title: MosaiQ COVID-19 Antibody Magazine - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/142486/download
    title: MosaiQ COVID-19 Antibody Magazine - IFU
  method: serological
  settings:
  - H
  technology: Total Antibody, photometric immunoassay
  type: diagnostic
- approval_date: 2020-09-29
  device: DiaSorin LIAISON SARS-CoV-2 IgM Assay
  entity: DiaSorin, Inc.
  last_update: 2020-09-29
  links:
  - href: https://www.fda.gov/media/142549/download
    title: DiaSorin LIAISON SARS-CoV-2 IgM Assay - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142550/download
    title: DiaSorin LIAISON SARS-CoV-2 IgM Assay - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142551/download
    title: DiaSorin LIAISON SARS-CoV-2 IgM Assay - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/142552/download
    title: DiaSorin LIAISON SARS-CoV-2 IgM Assay - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM, Indirect CLIA
  type: diagnostic
- approval_date: 2020-09-29
  device: FREND COVID-19 total Ab
  entity: NanoEntek America, Inc.
  last_update: 2020-09-29
  links:
  - href: https://www.fda.gov/media/142554/download
    title: FREND COVID-19 total Ab - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142555/download
    title: FREND COVID-19 total Ab - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142556/download
    title: FREND COVID-19 total Ab - Fact Sheet for Recipients
  - href: https://www.fda.gov/media/142557/download
    title: FREND COVID-19 total Ab - Instructions for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: Total Antibody, FIA
  type: diagnostic
- approval_date: 2020-09-29
  device: Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit
  entity: Nirmidas Biotech, Inc.
  last_update: 2020-09-29
  links:
  - href: https://www.fda.gov/media/142558/download
    title: Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit - Letter
      of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142559/download
    title: Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit - Fact Sheet
      for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142560/download
    title: Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit - Fact Sheet
      for Recipients
  - href: https://www.fda.gov/media/142561/download
    title: Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit - Instructions
      for Use
    type: instructions for use
  method: serological
  settings:
  - H
  - M
  technology: IgM and IgG, Lateral Flow
  type: diagnostic
- approval_date: 2020-06-02
  device: Elecsys IL-6
  entity: Roche Diagnostics
  last_update: 2020-06-02
  links:
  - href: https://www.fda.gov/media/138596/download
    title: Roche IL6 Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/138594/download
    title: Roche IL6 Fact Sheet for Healthcare Provider
  - href: https://www.fda.gov/media/138597/download
    title: Roche IL6 Factsheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/138595/download
    title: Roche IL6 Instruction for Use
  method: management
  settings:
  - H
  - M
  technology: Immunoassay-IL-6
  type: diagnostic
- approval_date: 2020-10-01
  device: Access IL-6
  entity: Beckman Coulter, Inc.
  last_update: 2020-10-01
  links:
  - href: https://www.fda.gov/media/142597/download
    title: Access IL-6 - Letter of Authorization
    type: letter of authorization
  - href: https://www.fda.gov/media/142598/download
    title: Access IL-6 - Fact Sheet for Healthcare Providers
    type: fact sheet for healthcare providers
  - href: https://www.fda.gov/media/142599/download
    title: Access IL-6 - Fact Sheet for Patients
    type: fact sheet for patients
  - href: https://www.fda.gov/media/142600/download
    title: Access IL-6 - IFU
  method: management
  settings:
  - H
  - M
  technology: One-step immunoenzymatic ("sandwich") assay, IL-6
  type: diagnostic
